Document And Entity Information
Document And Entity Information | 3 Months Ended |
Sep. 30, 2015 | |
Document Information [Line Items] | |
Entity Registrant Name | Propanc Health Group Corp |
Entity Central Index Key | 1,517,681 |
Entity Filer Category | Smaller Reporting Company |
Document Type | S1 |
Amendment Flag | false |
Document Period End Date | Sep. 30, 2015 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) | Sep. 30, 2015 | Jun. 30, 2015 | Jun. 30, 2014 |
CURRENT ASSETS: | |||
Cash | $ 77,458 | $ 107,627 | $ 87,799 |
GST tax receivable | 15,109 | 11,647 | 946 |
Prepaid expenses and other current assets | 207,347 | 502,616 | 25,000 |
TOTAL CURRENT ASSETS | 299,914 | 621,890 | 113,745 |
Security deposit | 1,535 | 1,684 | 0 |
Property and equipment, net | 3,672 | 3,494 | 0 |
TOTAL ASSETS | 305,121 | 627,068 | 113,745 |
CURRENT LIABILITIES: | |||
Accounts payable | 303,127 | 236,466 | 350,004 |
Accrued expenses and other payables | 429,198 | 386,311 | 422,326 |
Convertible notes and related accrued interest, net | 2,148,900 | 1,794,375 | 272,424 |
Loans payable | 6,278 | 27,558 | 33,909 |
Embedded conversion option liabilities | 350,063 | 780,281 | 0 |
Warrant derivative liability | 86,662 | 269,648 | 158,244 |
Due to directors - related parties | 31,994 | 35,108 | 60,350 |
Loans from directors and officer - related parties | 59,360 | 79,416 | 161,975 |
Employee benefit liability | 71,883 | 71,421 | 62,827 |
TOTAL CURRENT LIABILITIES | $ 3,487,465 | $ 3,680,584 | $ 1,522,059 |
Commitments and Contingencies | |||
STOCKHOLDERS' DEFICIT: | |||
Common stock, $0.001 par value; 2,000,000,000 shares authorized; 356,624,597 and 347,442,013 shares issued and outstanding as of September 30, 2015 and June 30, 2015, respectively | $ 356,625 | $ 347,442 | $ 72,685 |
Additional paid-in capital | 17,901,198 | 17,458,745 | 16,374,781 |
Accumulated other comprehensive income (loss) | 359,398 | 100,968 | (302,863) |
Accumulated deficit | (21,804,565) | (20,965,671) | (17,552,917) |
TOTAL STOCKHOLDERS' DEFICIT | (3,182,344) | (3,053,516) | (1,408,314) |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | 305,121 | 627,068 | 113,745 |
Series A Preferred Stock [Member] | |||
STOCKHOLDERS' DEFICIT: | |||
Preferred stock value | 5,000 | 5,000 | 0 |
TOTAL STOCKHOLDERS' DEFICIT | 5,000 | 0 | |
Series B Preferred Stock [Member] | |||
STOCKHOLDERS' DEFICIT: | |||
Preferred stock value | $ 0 | 0 | 0 |
TOTAL STOCKHOLDERS' DEFICIT | $ 0 | $ 0 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Sep. 30, 2015 | Jun. 30, 2015 | Jun. 30, 2014 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | $ 0.001 |
Common stock, authorized shares | 2,000,000,000 | 2,000,000,000 | 2,000,000,000 |
Common stock, issued shares | 356,624,597 | 347,442,013 | 72,684,767 |
Common stock, outstanding shares | 356,624,597 | 347,442,013 | 72,684,767 |
Series A Preferred Stock [Member] | |||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 |
Preferred stock, authorized shares | 10,000,000 | 10,000,000 | 10,000,000 |
Preferred stock, issued shares | 500,000 | 500,000 | 0 |
Preferred stock, outstanding shares | 500,000 | 500,000 | 0 |
Series B Preferred Stock [Member] | |||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 |
Preferred stock, authorized shares | 5 | 5 | 5 |
Preferred stock, issued shares | 1 | 1 | 0 |
Preferred stock, outstanding shares | 1 | 1 | 0 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2015 | Sep. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
REVENUE | ||||
Revenue | $ 0 | $ 0 | $ 0 | $ 0 |
OPERATING EXPENSES | ||||
Administration expenses | 848,979 | 231,482 | 1,567,549 | 742,037 |
Occupancy expenses | 4,938 | 2,777 | 3,719 | 11,016 |
Research and development | 153,474 | 3,879 | 134,319 | 8,168 |
TOTAL OPERATING EXPENSES | 1,007,391 | 238,138 | 1,705,587 | 761,221 |
LOSS FROM OPERATIONS | (1,007,391) | (238,138) | (1,705,587) | (761,221) |
OTHER INCOME (EXPENSE) | ||||
Interest expense | (418,644) | (548,479) | (1,323,902) | (93,147) |
Interest income | 2,027 | 3 | 33 | 18 |
Other expense | 0 | (50,002) | (50,002) | 0 |
Change in fair value of derivative liabilities | 795,853 | 114,536 | (541,981) | (16,522) |
Gain on debt settlements, net | 0 | (36,263) | 375,547 | 0 |
Foreign currency transaction loss | (210,739) | (24,957) | (244,332) | (6,959) |
TOTAL OTHER INCOME (EXPENSE) | 168,497 | (545,162) | (1,784,637) | (116,610) |
LOSS BEFORE INCOME TAXES | (838,894) | (783,300) | (3,490,224) | (877,831) |
INCOME TAX BENEFIT | 0 | 0 | 77,470 | 48,267 |
NET INCOME (LOSS) | (838,894) | (783,300) | (3,412,754) | (829,564) |
OTHER COMPREHENSIVE INCOME (LOSS) | ||||
Foreign currency translation gain (loss) | 258,430 | 114,817 | 403,831 | (58,274) |
TOTAL OTHER COMPREHENSIVE INCOME (LOSS) | $ (580,464) | $ (668,483) | $ (3,008,923) | $ (887,838) |
BASIC AND DILUTED NET LOSS PER SHARE (in dollars per share) | $ 0 | $ (0.01) | $ (0.02) | $ (0.01) |
BASIC AND DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING (in shares) | 350,228,617 | 76,297,745 | 177,633,496 | 72,350,555 |
CONSOLIDATED STATEMENT OF CHANG
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($) | Total | Common stock issuable [Member] | Common Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Deficit [Member] | Accumulated Other Comprehensive Income (Loss) [Member] | Series A Preferred Stock [Member] | Series B Preferred Stock [Member] |
Balance at Jun. 30, 2013 | $ (792,476) | $ 25 | $ 70,632 | $ 16,104,809 | $ (16,723,353) | $ (244,589) | $ 0 | $ 0 |
Balance (in shares) at Jun. 30, 2013 | 25,000 | 70,632,267 | 0 | 0 | ||||
Issuance of stock for services | 244,500 | $ (25) | $ 1,915 | 242,610 | 0 | 0 | $ 0 | $ 0 |
Issuance of stock for services (in shares) | (25,000) | 1,915,000 | 0 | 0 | ||||
Issuance of common stock for conversion of accrued expenses | 27,500 | $ 0 | $ 138 | 27,362 | 0 | 0 | $ 0 | $ 0 |
Issuance of common stock for conversion of accrued expenses (in shares) | 0 | 137,500 | 0 | 0 | ||||
Foreign currency translation gain/loss | (58,274) | $ 0 | $ 0 | 0 | 0 | (58,274) | $ 0 | $ 0 |
Net loss | (829,564) | 0 | 0 | 0 | (829,564) | 0 | 0 | 0 |
Balance at Jun. 30, 2014 | (1,408,314) | $ 0 | $ 72,685 | 16,374,781 | (17,552,917) | (302,863) | $ 0 | $ 0 |
Balance (in shares) at Jun. 30, 2014 | 0 | 72,684,767 | 0 | 0 | ||||
Issuance of common stock for cash | 29,000 | $ 0 | $ 13,400 | 15,600 | 0 | 0 | $ 0 | $ 0 |
Issuance of common stock for cash (in shares) | 0 | 13,400,000 | 0 | 0 | ||||
Issuance of common stock for conversion of convertible debt | 441,160 | $ 0 | $ 181,185 | 259,975 | 0 | 0 | $ 0 | $ 0 |
Issuance of common stock for conversion of convertible debt (in shares) | 0 | 181,185,110 | 0 | 0 | ||||
Issuance of stock for services | 741,276 | $ 0 | $ 19,258 | 717,018 | 0 | 0 | $ 5,000 | $ 0 |
Issuance of stock for services (in shares) | 0 | 19,258,316 | 500,000 | 1 | ||||
Issuance of common stock as part of settlement agreement | 152,285 | $ 0 | $ 60,914 | 91,371 | 0 | 0 | $ 0 | $ 0 |
Issuance of common stock as part of settlement agreement (in shares) | 0 | 60,913,820 | 0 | 0 | ||||
Foreign currency translation gain/loss | 403,831 | $ 0 | $ 0 | 0 | 0 | 403,831 | $ 0 | $ 0 |
Net loss | (3,412,754) | 0 | 0 | 0 | (3,412,754) | 0 | 0 | 0 |
Balance at Jun. 30, 2015 | (3,053,516) | $ 0 | $ 347,442 | $ 17,458,745 | $ (20,965,671) | $ 100,968 | $ 5,000 | $ 0 |
Balance (in shares) at Jun. 30, 2015 | 0 | 347,442,013 | 500,000 | 1 | ||||
Net loss | (838,894) | |||||||
Balance at Sep. 30, 2015 | $ (3,182,344) |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2015USD ($) | Sep. 30, 2014USD ($) | Jun. 30, 2015USD ($) | Jun. 30, 2014USD ($) | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||
Net loss | $ (838,894) | $ (783,300) | $ (3,412,754) | $ (829,564) |
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities: | ||||
Issuance of common stock for services and voluntary ratchet | 458,331 | 69,726 | 276,792 | 237,833 |
Issuance of preferred stock for services | 1,067 | 0 | ||
Fair value of warrants issued for services | 51,488 | 0 | ||
(Gain) loss on settlement | 0 | 405,002 | (375,547) | 0 |
Settlement fees paid in the form of debt | 150,000 | 0 | ||
Amortization of prepaid shares issued for services | 0 | 6,667 | ||
Foreign currency transaction loss | (10,784) | 0 | 31,548 | 0 |
Depreciation expense | 171 | 0 | 81 | 538 |
Amortization of debt discount | 206,935 | 98,013 | 295,795 | 49,029 |
Change in fair value of derivative liabilities | (795,853) | (114,536) | 541,981 | 16,522 |
Promissory note payable issued for services | 0 | 50,000 | ||
Accretion of put premium | 154,198 | 83,636 | 1,044,196 | 27,187 |
Original issue discount | 0 | 2,500 | ||
Changes in Assets and Liabilities: | ||||
GST receivable | (4,495) | (1,705) | (10,879) | 0 |
Prepaid expenses and other assets | 8,192 | (7,117) | (74,303) | 294 |
Accounts payable | 87,636 | 79,500 | (47,977) | 94,607 |
Employee benefit liability | 6,797 | 1,920 | 20,362 | 11,598 |
Accrued expenses | 77,152 | 16,551 | 115,941 | 158,847 |
Accrued interest | 23,379 | 0 | (34,270) | 0 |
NET CASH USED IN OPERATING ACTIVITIES | (627,235) | (99,810) | (1,426,479) | (226,442) |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||
Payment for security deposit | (1,684) | 0 | ||
Purchase of equipment | (679) | 0 | (3,901) | 0 |
NET CASH USED IN INVESTING ACTIVITIES | (679) | 0 | (5,585) | 0 |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||
Bank overdraft | 0 | (6) | ||
Loan repayments to principal stockholder | (13,549) | (8,725) | (28,455) | (45,512) |
Loan repayments | (19,613) | 0 | ||
Investor advances - related party | 0 | 2,164 | ||
Proceeds from convertible promissory notes | 552,500 | 22,700 | 1,438,500 | 273,959 |
Repayments of convertible promissory notes | (104,000) | 0 | (157,000) | 0 |
Proceeds from issuance of common stock for cash | 29,000 | 0 | ||
Loan proceeds | 0 | 10,542 | ||
Loan proceeds from principal stockholder | 0 | 72,158 | ||
NET CASH PROVIDED BY FINANCING ACTIVITIES | 415,338 | 16,139 | 1,282,045 | 311,141 |
Effect of exchange rate changes on cash | 182,407 | 385 | 169,847 | 3,100 |
NET INCREASE (DECREASE) IN CASH | (30,169) | (83,286) | 19,828 | 87,799 |
CASH AT BEGINNING OF PERIOD | 107,627 | 87,799 | 87,799 | 0 |
CASH AT END OF PERIOD | 77,458 | 4,513 | 107,627 | 87,799 |
Cash paid during the period: | ||||
Interest | 0 | 0 | 0 | 0 |
Income Tax | 0 | 0 | 0 | 0 |
Supplemental Disclosure of Non-Cash Investing and Financing Activities | ||||
Common stock issued for settlement of debt | 152,285 | 0 | ||
Prepaid common stock issued for services | 18,139 | 0 | 269,682 | 6,667 |
Prepaid warrants issued for services | 138,314 | 0 | ||
Reduction of put premium related to conversions of convertible note | 122,727 | 0 | 71,370 | 0 |
Conversion of accrued expenses to common stock | 0 | 27,500 | ||
Conversion of convertible notes and accrued interest to common stock | 278,487 | 152,102 | 374,771 | 0 |
Discounts related to warrants issued with convertible debenture | 0 | 133,095 | ||
Discounts related to lender costs | 0 | 27,500 | 48,500 | 30,000 |
Discounts related to derivative liability | 200,000 | 0 | 305,000 | 0 |
Conversion of loan payable to convertible debenture | 0 | 27,963 | ||
Conversion of loan payable to common stock | $ 0 | $ 67,892 | 66,389 | 0 |
Prepaid settlement fee paid through issuance of convertible note | $ 0 | $ 25,000 |
NATURE OF OPERATIONS AND SUMMAR
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Accounting Policies [Abstract] | ||
NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES [Text Block] | NOTE 1 NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES Propanc PTY LTD was incorporated in Melbourne, Victoria Australia on October 15, 2007, and is based in Richmond, Victoria Australia. Since inception, substantially all of the efforts of the Company have been the development of new cancer treatments targeting high risk patients who need a follow up, nontoxic, long term therapy which prevents the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. On November 23, 2010, Propanc Health Group Corporation ("the Company", "we", "us", "our") was incorporated in the state of Delaware. In January 2011, to reorganize the Company, Propanc Health Group Corporation acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary. The interim unaudited consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our results of operations and cash flows for the three months ended September 30, 2015 and 2014 and our financial position as of September 30, 2015 have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year. Certain information and disclosures normally included in the notes to the annual audited consolidated financial statements have been condensed or omitted from these interim unaudited consolidated financial statements. Accordingly, these interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2015. The June 30, 2015 balance sheet is derived from those statements. The unaudited consolidated financial statements include the accounts of Propanc Health Group Corporation and its wholly-owned subsidiary, Propanc PTY LTD. All significant inter-company balances and transactions have been eliminated in consolidation. The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying unaudited consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates. The Company’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into United States dollars ($) and/or USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the statements of operations and other comprehensive income (loss) as other income (expense). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Comprehensive income (loss) for all periods presented, includes only foreign currency translation gains (losses). Changes in Accumulated Other Comprehensive Income (Loss) by Component during the three months ended September 30, 2015 was as follows: Foreign Beginning balance, June 30, 2015 $ 100,968 Foreign currency translation gain 258,430 Ending balance, September 30, 2015 $ 359,398 The Company measures their financial assets and liabilities in accordance with US GAAP. For certain of the Company’s financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued expenses and other liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for loans payable, also approximate fair value because current interest rates available to us for debt with similar terms and maturities are substantially the same. The Company adopted accounting guidance for fair value measurements of financial assets and liabilities. The adoption did not have a material impact on the Company’s results of operations, financial position or liquidity. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were no cash equivalents as of September 30, 2015 or June 30, 2015. Patent costs are stated at cost and reclassified to intangible assets and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency, however, the Company will expense any costs as long as the Company is in the startup stage. Accordingly, as the Company's product was and is not currently approved for market, thus any patent costs incurred from 2013 through 2015 were expensed immediately. Currently, the Company has one International patent pending which was jointly applied for by the Company and another entity. The Company received grant status, or has been accepted in South Africa, Australia, and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of the Company’s technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, whilst also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions where the Company is actively seeking patent protection include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is now granted, or accepted in South Africa, Australia, and New Zealand. In accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Revenues, expenses and balance sheet items are recognized net of the amount of GST except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office. Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows. As of September 30, 2015 and June 30, 2015 the Company was owed $15,109 and $11,647 from the Australian Taxation Office. These amounts were fully collected subsequent to the balance sheet reporting dates. ASC Topic 815, Derivatives and Hedging The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480 and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion, and records the put premium as accretion to interest expense to the date of first conversion. The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The Company adopted provisions of ASC 740, Sections 25 through 60, “Accounting for Uncertainty in Income Taxes." These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods. In accordance with ASC 730-10, research and development costs are expensed when incurred. Total research and development costs for the three months ended September 30, 2015 and 2014 were $153,474 and $3,879 respectively. The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income then the Company can receive the credit which reduces its income tax liability. If the Company has net losses then the Company may still receive a cash payment for the credit, however, the Company's net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as an income tax benefit, in operations, upon receipt. The Company records stock based compensation in accordance with ASC section 718, “Stock Compensation” and Staff Accounting Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes Option Pricing Model. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50 “Equity-Based Payments to Non-Employees”. In accordance with SEC Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. For the three months ended September 30 2015 and 2014, there were 7,379,158 and 3,000,000 warrants respectively outstanding and fourteen and four convertible notes payable that are convertible into 228,300,369 and 18,823,721 common shares respectively which are considered dilutive securities which were excluded from the computation since the effect is anti-dilutive. Financial Accounting Standards Board, Accounting Standard Updates which are not effective until after September 30, 2015 are not expected to have a significant effect on the Company’s consolidated financial position or results of operations. The Company is evaluating the following at September 30, 2015: In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements Going Concern (Topic 205-40)”, which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard will be effective for the Company for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company expects to adopt this new standard as of December 31, 2016. The Company does not expect this ASU to have a material impact on its consolidated financial statements. On May 8, 2015, the FASB issued ASU 2015-08, “Business Combinations (Topic 805) Pushdown Accounting In April 2015, the Financial Accounting Standards Board issued Accounting Standards Update No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs," | NOTE 1 NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES Propanc PTY LTD was incorporated in Melbourne, Victoria Australia on October 15, 2007, and is based in Richmond, Victoria Australia. Since inception, substantially all of the efforts of the Company have been the development of new cancer treatments targeting high risk patients who need a follow up, nontoxic, long term therapy which prevents the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. On November 23, 2010, Propanc Health Group Corporation ("the Company", "we", "us", "our") was incorporated in the state of Delaware. In January 2011, to reorganize the Company, Propanc Health Group Corporation acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary. The consolidated financial statements include the accounts of Propanc Health Group Corporation and its wholly-owned subsidiary, Propanc PTY LTD. All significant inter-company balances and transactions have been eliminated in consolidation. The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates. The Company’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into United States dollars ($) and/or USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the statement of operations and comprehensive loss as other income (expense). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Comprehensive income (loss) for all periods presented, includes only foreign currency translation gains (losses). Foreign Currency Items: Beginning balance, June 30, 2013 $ (244,589) Foreign currency translation loss (58,274) Balance, June 30, 2014 (302,863) Foreign currency translation gain 403,831 Ending balance, June 30, 2015 $ 100,968 The Company measures their financial assets and liabilities in accordance with US GAAP. For certain of the Company’s financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued expenses and other liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for loans payable, also approximate fair value because current interest rates available to us for debt with similar terms and maturities are substantially the same. The Company adopted accounting guidance for fair value measurements of financial assets and liabilities. The adoption did not have a material impact on the Company’s results of operations, financial position or liquidity. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were no cash equivalents as of June 30, 2015 or 2014. As amounts become uncollectible, they will be charged to an allowance and operations in the period when a determination of uncollectability is made. Any estimates of potentially uncollectible customer accounts receivable will be made based on an analysis of individual customer and historical write-off experience. The Company’s analysis included the age of the receivable account, creditworthiness of the customer and general economic conditions. Property and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred; additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value. The estimated useful lives are as follows: Machinery and equipment 5 Patent costs are stated at cost and reclassified to intangible assets and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency, however, the Company will expense any costs as long as the Company is in the startup stage. Accordingly, as the Company's product was and is not currently approved for market, thus any patent costs incurred from 2013 through 2015 were expensed immediately. Currently, the Company has one International patent pending which was jointly applied for by the Company and another entity. The Company received grant status , or been accepted in South Africa, Australia, and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of the Company’s technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, whilst also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions where the Company is actively seeking patent protection include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is now granted , or accepted in South Africa, Australia, and New Zealand. In accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Liabilities arising in respect of wages and salaries, annual leave, accumulated sick leave and any other employee benefits expected to be settled within twelve months of the reporting date are measured at their nominal amounts based on remuneration rates which are expected to be paid when the liability is settled. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve months and therefore, recorded at nominal value. Revenues, expenses and balance sheet items are recognized net of the amount of GST except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office. Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows. As of June 30, 2015 and June 30, 2014 the Company was owed $ 11,647 946 ASC Topic 815, Derivatives and Hedging The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480 and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion, and records the put premium as accretion to interest expense to the date of first conversion. The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The Company adopted provisions of ASC 740, Sections 25 through 60, “Accounting for Uncertainty in Income Taxes." These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods. Upon the adoption of ASC 740, the Company had no unrecognized tax benefits. During the years ended June 30, 2015 and 2014 no adjustments were recognized for uncertain tax benefits. The years 2008 through 2015 are subject to examination by the Australian Taxation Office. The years ended June 30, 2012 through 2015 is subject to examination by the United States Internal Revenue Service. In accordance with ASC 730-10, research and development costs are expensed when incurred. Total research and development costs for the years ended June 30, 2015 and 2014 were $ 134,319 8,168 The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income then the Company can receive the credit which reduces its income tax liability. If the Company has net losses then the Company may still receive a cash payment for the credit, however, the Company's net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as an income tax benefit, in operations, upon receipt. During the years ended June 30, 2015 and 2014, the Company applied for and received from the Australian Taxation Office a research and development tax credit in the amount of $ 77,470 48,267 The Company records stock based compensation in accordance with ASC section 718, “Stock Compensation” and Staff Accounting Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes Option Pricing Model. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50 “Equity-Based Payments to Non-Employees”. In accordance with SEC Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition, In accordance with ASC 720-15-15, start-up costs are expensed as incurred. Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. For the years ended June 30 2015 and 2014, there were 7,379,158 3,000,000 335,716,597 6,069,667 Financial Accounting Standards Board, Accounting Standard Updates which are not effective until after June 30, 2015 are not expected to have a significant effect on the Company’s consolidated financial position or results of operations. The Company implemented the following at June 30, 2015: In June 2014, the FASB issued ASU No. 2014-10, which amended Accounting Standards Codification (ASC) Topic 915 Development Stage Entities. The amendment eliminates certain financial reporting requirements surrounding development stage entities, including an amendment to the variable interest entities guidance in ASC Topic 810, Consolidation. The amendment removes the definition of a development stage entity from the ASC, thereby removing the financial reporting distinction between development stage entities and other entities from U.S. GAAP. Consequently, the amendment eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. This amendment is effective for fiscal years beginning after December 15, 2014, and interim periods therein. Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued. The Company has made the election to early adopt this amendment effective June 30, 2014 and, as a result, the Company is no longer presenting or disclosing the information previously required under Topic 915. The early adoption was made to reduce data maintenance by removing all incremental financial reporting requirements for development stage entities. The adoption of this amendment alters the disclosure requirements of the Company, but it does not have any material impact on the Company's financial position or results of operations for the current or any prior reporting periods. In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements Going Concern (Topic 205-40)”, which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard will be effective for the Company for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company expects to adopt this new standard as of December 31, 2015. The Company does not expect this ASU to have a material impact on its consolidated financial statements. On May 8, 2015, the FASB issued ASU 2015-08, “Business Combinations (Topic 805) Pushdown Accounting In April 2015, the Financial Accounting Standards Board issued Accounting Standards Update No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs," |
GOING CONCERN
GOING CONCERN | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Accounting Policies [Abstract] | ||
Going Concern [Text Block] | NOTE 2 GOING CONCERN The accompanying unaudited consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. For the three months ended September 30, 2015, the Company had no revenues and had a net loss of $838,894 and net cash used in operations of $627,235. Additionally, as of September 30, 2015, the Company had a working capital deficit, stockholders' deficit and accumulated deficit of $3,187,551, $3,182,344, and $21,804,565 respectively. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated unaudited financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty. Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company's International patent application and achieving a level of sales adequate to support the Company’s cost structure. However, there can be no assurances that the Company will be able to secure additional equity investment or achieve an adequate sales level. | NOTE 2 GOING CONCERN The accompanying consolidated financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company as a going concern. For the year ended June 30, 2015, the Company had no revenues and had a net loss of $ 3,412,754 1,426,479 3,058,694 3,053,516 20,965,671 Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company's International patent application and achieving a level of sales adequate to support the Company’s cost structure. However, there can be no assurances that the Company will be able to secure additional equity investment or achieve an adequate sales level. |
DUE TO DIRECTORS - RELATED PART
DUE TO DIRECTORS - RELATED PARTIES | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Due to Related Parties [Abstract] | ||
Due To Directors Related Party [Text Block] | NOTE 3 DUE TO DIRECTORS - RELATED PARTIES Due to directors - related parties represents unsecured advances made by the directors for operating expenses on behalf of the Company such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company are due upon demand. The Company is currently not being charged interest under these advances. The total amount owed these directors at September 30, 2015 and June 30, 2015 is $31,994 and $35,108 respectively. | NOTE 4 DUE TO DIRECTORS - RELATED PARTIES Due to directors - related parties represents unsecured advances made by the directors for operating expenses on behalf of the Company such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company and are due upon demand. The Company is currently not being charged interest under these advances. The total amount owed these directors at June 30, 2015 and June 30, 2014 is $ 35,108 60,350 44,000 44,000 14,000 |
PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT | 12 Months Ended |
Jun. 30, 2015 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment Disclosure [Text Block] | NOTE 3 PROPERTY AND EQUIPMENT Property, plant, and equipment consist of the following as of June 30, 2015 2014 Office equipment at cost $ 15,732 $ 14,968 Less: Accumulated depreciation (12,238) (14,968) Total property, plant, and equipment $ 3,494 $ - Depreciation expense for the years ended June 30, 2015 and 2014 were $81 and $538 respectively. |
LOANS
LOANS | 3 Months Ended |
Sep. 30, 2015 | |
Receivables [Abstract] | |
Financing Receivables [Text Block] | NOTE 4 LOANS Loans from Directors and Officer - Related Parties Loans from Directors and an Officer at September 30, 2015 and June 30, 2015 were $59,360 and $79,416, respectively. The loans bear no interest and are all past their due date and in default. The Company repaid cash of $13,549 (AUD$18,652) of these loans during the three months ended September 30, 2015. Other Loans from Unrelated Parties As of June 30, 2015, other loans from unrelated parties balance was $27,558. During the three months ended September 30, 2015, the Company repaid cash of $19,613 (AUD$27,000) and a foreign currency transaction gain of $1,667 resulting in a balance of $6,278 as of September 30, 2015. |
CONVERTIBLE NOTES
CONVERTIBLE NOTES | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Debt Disclosure [Abstract] | ||
Debt Disclosure [Text Block] | NOTE 5 CONVERTIBLE NOTES Convertible notes and debenture $ 1,773,500 Unamortized discounts (448,532) Accrued interest 57,295 Premium 766,637 Convertible notes, net $ 2,148,900 On August 6, 2014 (execution date), the Company executed a convertible promissory note in the principal sum of $ 250,000 25,000 10 0 12 25,000 2,500 2,965 On February 10, 2015, the Company issued a convertible note payable for $ 45,000 7,500 The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is February 10, 2016. The note is convertible at the option of the holder at any time after 180 days at a rate of 55% of the lowest trading bid price of the Company’s common stock for the ten prior trading days prior to the date upon which the conversion notice was received. 36,818 9,409 27,409 1,887 36,818 On February 17, 2015, the Company issued a second convertible note payable for $ 45,000 7,500 The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is February 17, 2016. The note is convertible at the option of the holder at any time after 180 days at a rate of 55% of the lowest trading bid price of the Company’s common stock for the ten prior trading days prior to the date upon which the conversion notice was received 36,818 9,409 27,409 45,000 2,229 36,818 On March 12, 2015, the Company issued a third convertible note payable for $ 170,500 13,000 The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is March 12, 2016. The note is convertible at the option of the holder at any time at a rate of 55% of the Company’s common stock for the average of the lowest three trading prices in the ten prior trading days including the date upon which the conversion notice was received 139,500 15,000 667 12,273 6,919 On March 20, 2015, the Company issued a fourth convertible note payable for $ 150,000 The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is March 20, 2016. The note is convertible at the option of the holder at any time at a rate of 55% of the lowest trading bid price of the Company’s common stock for the average of the lowest three trading priced in the ten prior trading days including the date upon which the conversion notice was received. 122,727 6,411 In addition to each of the above initial convertible promissory notes (“initial convertible notes”), the Company issued to each lender another convertible promissory note for the same amounts of $ 45,000 45,000 170,500 150,000 In the event the Company redeems the initial convertible notes in full, the Company is required to pay off all principal, interest and any other amounts owing multiplied by i) 130 140 150 In the event of two specific defaults, which include the maintenance of a minimum trading price and an aggregate dollar trading volume of the Company's common shares, the holders may cancel the Back-End Notes and the related Notes Receivable and otherwise in the event of other defaults as defined in the securities purchase agreement, the amount of principal and accrued interest will become immediately due and payable and may be offset by amounts due to the Company by the holders. Additionally, the Back-End Notes will bear default interest at a rate of 24% per annum, or the highest rate of interest permitted by law. On February 15, 2015, in connection with a six-month consulting agreement, the Company issued a convertible promissory note for $ 90,000 5 60 60,000 2,811 On March 12, 2015, the Company issued a convertible promissory note for $ 104,000 8 December 16, 2015 58 75,310 180 137,915 104,000 2,872 31,043 6,276 46,441 22,593 On March 12, 2015, in connection with a two-year consulting agreement, the Company issued a convertible promissory note for $ 60,000 10 March 11, 2017 0.0175 75 3,337 On April 20, 2015, the Company issued a convertible note payable for $17,500. The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is April 20, 2016. The note is convertible at the option of the holder at any time at a rate of 55% of the lowest trading bid price of the Company’s common stock for the ten prior trading days including the date upon which the conversion notice was received. The convertible note is treated as stock settled debt under ASC 480 and accordingly the Company recognized a $14,318 put premium. Accrued interest as of September 30, 2015 was $ 625 On April 24, 2015, the Company received payment of the Note Receivable of $ 45,000 7,500 2,250 35,250 55 36,818 180 22,909 13,909 45,000 1,765 36,818 On April 24, 2015, the Company received payment of the Note Receivable of $ 45,000 7,500 2,250 35,250 55 36,818 32,727 1,578 On April 27, 2015, the Company received payment of the Note Receivable of $ 170,500 13,000 7,500 150,000 55 139,500 5,867 On May 19, 2015, the Company entered into a Securities Purchase Agreement (“SPA”), to issue a series of nine back end convertible notes in the principal sum of $ 782,500 37,500 37,500 157,500 150,000 17,500 37,500 37,500 157,500 150,000 The Back-End Notes may not be prepaid, except that if the initial convertible notes are redeemed by the Company within six months of their issuance, all obligations of the Company and holders under the Back-End Notes and the Notes Receivable will be deemed satisfied and such notes shall automatically be deemed cancelled and of no further force or effect. In the event of two specific defaults, which include the maintenance of a minimum trading price and an aggregate dollar trading volume of the Company's common shares, the holders may cancel the Back-End Notes and the related Notes Receivable and otherwise in the event of other defaults as defined in the securities purchase agreement, the amount of principal and accrued interest will become immediately due and payable and may be offset by amounts due to the Company by the holders. Additionally, the Back-End Notes will bear default interest at a rate of 24% per annum, or the highest rate of interest permitted by law. Since the Back-End Notes are not convertible until the Notes Receivable are paid, and the Notes Receivable and Back-End Notes have a right of setoff, the Notes Receivable and Back-End Notes and related accrued interest receivable and payable have been netted for presentation purposes on the accompanying consolidated balance sheet. On June 2, 2015, the Company received payment of the Note Receivable of $ 150,000 7,500 142,500 55 122,727 5,162 On June 4, 2015 (execution date), the Company executed a convertible promissory note in the principal sum of $ 1,215,000 110,000 10 335,000 30,000 5,000 220,000 20,000 220,000 20,000 300,000 30,000 5,000 1,997 201,997 0.07 0.07 3,000,000 10 15,593 On July 14, 2015, the Company received payment of three Note Receivables of $ 352,500 17,690 334,810 288,409 147,409 6,026 The Company recorded $ 220,000 30,000 186,935 10,171 | NOTE 6 CONVERTIBLE NOTES June 30, 2015 June 30, 2014 Convertible notes and debenture $ 1,455,000 $ 366,296 Unamortized discounts (415,467) (121,059) Accrued interest 26,989 - Premium, net 727,853 27,187 Convertible notes, net $ 1,794,375 $ 272,424 On September 30, 2013 the Company’s subsidiary issued a Debenture for $ 139,680 150,000 3,000,000 12 27,963 63,196 46,446 0.075 0.0698 0.20 0.075 53 27 0.4 400,000 140,000 260,000 139,680 15,118 0.0709 0.075 2,183,333 On May 8, 2014, the Company issued a 10 25,000 25,000 25,000 1,466 On May 29, 2014, the Company issued a convertible note payable for $ 75,000 8 May 29, 2015 180 55 61,364 180 51,089 10,275 14,547 218 61,364 60,453 4,352 On May 29, 2014, the Company issued a second convertible note payable for $ 75,000 8 May 29, 2015 55 61,364 51,089 10,275 11,755 553 61,364 63,245 3,313 On May 30, 2014, the Company issued a third convertible note payable for $ 50,000 8 May 30, 2015 180 55 40,909 34,273 6,636 50,000 3,346 40,909 In addition to each of the above initial convertible promissory notes (“initial convertible notes”), the Company issued to each lender another convertible promissory note for the same amounts of $ 75,000 75,000 50,000 In the event the Company redeems the initial convertible notes in full, the Company is required to pay off all principal, interest and any other amounts owing multiplied by i) 130 140 150 In the event of two specific defaults, which include the maintenance of a minimum trading price and an aggregate dollar trading volume of the Company's common shares, the holders may cancel the Back-End Notes and the related Notes Receivable and otherwise in the event of other defaults as defined in the securities purchase agreement, the amount of principal and accrued interest will become immediately due and payable and may be offset by amounts due to the Company by the holders. Additionally, the Back-End Notes will bear default interest at a rate of 16 Since the Back-End Notes are not convertible until the Notes Receivable are paid and also not for 180 days from the note dates, and the Notes Receivable and Back-End Notes have a right of setoff, the Notes Receivable and Back-End Notes and related accrued interest receivable and payable have been netted for presentation purposes on the accompanying consolidated balance sheet. On August 6, 2014 (execution date), the Company executed a convertible promissory note in the principal sum of $ 250,000 25,000 10 0 12 0.09 60 12 2,134 250,000 On November 17, 2014, the Company issued a convertible promissory note for $ 43,000 8 August 20, 2015 180 58 31,138 27,851 61,632 43,000 1,527 17,105 3,287 On December 10, 2014, the Company issued a convertible promissory note for $ 28,000 8 September 12, 2015 180 58 20,276 15,657 38,654 28,000 853 9,801 4,619 On January 26, 2015, the Company issued a convertible promissory note for $ 28,000 8 October 28, 2015 180 58 20,276 15,432 37,137 28,000 835 8,302 4,844 On January 27, 2015, the Company received payment of the Note Receivable of $ 50,000 7,779 2,500 5,000 34,721 55 40,909 180 40,909 50,000 609 40,909 On February 10, 2015, the Company issued a convertible note payable for $ 45,000 7,500 8 February 10, 2016 180 55 36,818 27,409 1,391 On February 17, 2015, the Company issued a second convertible note payable for $ 45,000 7,500 8 February 17, 2016 180 55 36,818 27,409 1,322 On March 12, 2015, the Company issued a third convertible note payable for $ 170,500 13,000 8 March 12, 2016 55 139,500 4,148 On March 20, 2015, the Company issued a fourth convertible note payable for $ 150,000 8 March 20, 2016 55 122,727 3,386 In addition to each of the above initial convertible promissory notes (“initial convertible notes”), the Company issued to each lender another convertible promissory note for the same amounts of $ 45,000 45,000 170,500 150,000 In the event the Company redeems the initial convertible notes in full, the Company is required to pay off all principal, interest and any other amounts owing multiplied by i) 130 140 150 In the event of two specific defaults, which include the maintenance of a minimum trading price and an aggregate dollar trading volume of the Company's common shares, the holders may cancel the Back-End Notes and the related Notes Receivable and otherwise in the event of other defaults as defined in the securities purchase agreement, the amount of principal and accrued interest will become immediately due and payable and may be offset by amounts due to the Company by the holders. Additionally, the Back-End Notes will bear default interest at a rate of 24 Since the Back-End Notes are not convertible until the Notes Receivable are paid and also not for 180 days from the note dates, and the Notes Receivable and Back-End Notes have a right of setoff, the Notes Receivable and Back-End Notes and related accrued interest receivable and payable have been netted for presentation purposes on the accompanying consolidated balance sheet. On February 15, 2015, in connection with a six-month consulting agreement, the Company issued a convertible promissory note for $ 90,000 5 August 15, 2015 60 60,000 1,677 On February 20, 2015, the Company issued a convertible promissory note for $ 58,000 12 July 27, 2015 180 50 58,000 36,411 83,512 58,000 2,212 23,300 21,589 On March 12, 2015, the Company issued a convertible promissory note for $ 104,000 8 December 16, 2015 180 58 75,310 46,441 2,530 137,915 104,000 2,872 (See Note 13) On March 12, 2015, in connection with a two-year consulting agreement, the Company issued a convertible promissory note for $ 60,000 10 March 11, 2017 0.0175 75 1,825 On April 20, 2015, the Company issued a convertible note payable for $ 17,500 8 April 20, 2016 55 14,318 272 On April 24, 2015, the Company received payment of the Note Receivable of $ 45,000 7,500 2,250 35,250 55 36,818 180 13,909 671 On April 24, 2015, the Company received payment of the Note Receivable of $ 45,000 7,500 2,250 35,250 55 36,818 180 13,909 671 On April 27, 2015, the Company received payment of the Note Receivable of $ 170,500 13,000 7,500 150,000 55 139,500 2,429 On May 19, 2015, the Company entered into a Securities Purchase Agreement (“SPA”), to issue a series of nine back end convertible notes in the principal sum of $ 782,500 37,500 37,500 157,500 150,000 17,500 37,500 37,500 157,500 150,000 55 The Back-End Notes may not be prepaid, except that if the initial convertible notes are redeemed by the Company within six months of their issuance, all obligations of the Company and holders under the Back-End Notes and the Notes Receivable will be deemed satisfied and such notes shall automatically be deemed cancelled and of no further force or effect. In the event of two specific defaults, which include the maintenance of a minimum trading price and an aggregate dollar trading volume of the Company's common shares, the holders may cancel the Back-End Notes and the related Notes Receivable and otherwise in the event of other defaults as defined in the securities purchase agreement, the amount of principal and accrued interest will become immediately due and payable and may be offset by amounts due to the Company by the holders. Additionally, the Back-End Notes will bear default interest at a rate of 24% per annum, or the highest rate of interest permitted by law. Since the Back-End Notes are not convertible until the Notes Receivable are paid, and the Notes Receivable and Back-End Notes have a right of setoff, the Notes Receivable and Back-End Notes and related accrued interest receivable and payable have been netted for presentation purposes on the accompanying consolidated balance sheet. On June 2, 2015, the Company received payment of the Note Receivable of $ 150,000 7,500 142,500 55 122,727 2,137 On June 4, 2015 (execution date), the Company executed a convertible promissory note in the principal sum of $ 1,215,000 110,000 10 335,000 30,000 5,000 220,000 20,000 220,000 20,000 40 300,000 30,000 5,000 0.07 3,000,000 2,513 The Company recorded $ 529,500 30,000 114,033 3,133 |
LOANS AND NOTES PAYABLE
LOANS AND NOTES PAYABLE | 12 Months Ended |
Jun. 30, 2015 | |
Notes and Loans Payable [Abstract] | |
Loans And Notes Payable Disclosure [Text Block] | NOTE 5 LOANS AND NOTES PAYABLE Loans from Directors and Officer - Related Parties Loans from Directors and an Officer at June 30, 2015 and June 30, 2014 were $ 79,416 161,975 127,000 109,000 33,259,350 17,654,470 27,000 14,000 0.0025 127,284 86,455 28,500 Other Loans from Unrelated Parties Loans from two unrelated parties were received during 2013 totaling $ 33,614 10 27,963 A loan from an unrelated party was received during the year ended June 30, 2014 totaling $ 9,419 10 A loan from an unrelated party was received during the year ended June 30, 2014 totaling $ 18,839 Accordingly, other loans totaled $ 33,909 In July 2014, the loans and notes payable balance of $ 33,909 27,558 Debt Settlement to be Paid in Stock, Net of Premium In July 2014, the Company consolidated outstanding debt and other liabilities as part of a settlement agreement (See Note 9) and was indebted to one unrelated party for approximately $ 1,033,000 50,000 355,000 628,000 7,426,000 8,161,000 81,396 575,000 310,000 50,000 17,000 Notes Payable On July 18, 2014, the Company paid a $ 50,000 50,000 10,000,000 50,000 25,000 1,466 0.0025 25,000 51,466 |
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Stockholders' Equity Note [Abstract] | ||
Stockholders' Equity Note Disclosure [Text Block] | NOTE 6 STOCKHOLDERS’ DEFICIT Preferred Stock: The total number of preferred shares authorized and that may be issued by the Company is 10,000,000 0.01 Of the total preferred shares authorized, pursuant to Certificate of Designation filed on December 9, 2014, 500,000 have been designated as Series A preferred stock, with a par value of $0.01 (“Series A Preferred Stock”). On December 9, 2014, the Company issued 500,000 shares of Series A Preferred Stock to its CEO in consideration for services rendered to the Company, including for and as an incentive to continue to assist and provide services to the Company. The shares were valued at $0.00213 per share for a total value of $1,067 based on the average sale price per share of the 8,161,000 shares of common stock sold during the three months ended December 31, 2014. Of the total preferred shares authorized, pursuant to Certificate of Designation filed on June 16, 2015, up to five ( 5 0.01 0.1165 0.12 Common Stock: On November 12, 2014, the Company filed an amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware, to increase the Company’s authorized common stock from one hundred million (100,000,000) shares of common stock, par value $0.001 per share, to ten billion (10,000,000,000) shares of common stock, par value $0.001 per share. On July 10, 2015, the Company filed an amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware, to decrease the Company’s authorized common stock from ten billion (10,000,000,000) shares of common stock, par value $0.001 per share, to two billion (2,000,000,000) shares of common stock, par value $0.001 per share. Shares issued for services On June 4, 2015, the Company entered into an agreement with a consultant to provide services over a six month period in exchange for 500,000 shares of common stock. The Company valued the 500,000 shares based on the market price on the agreement date of $0.0706 and will recognize $35,300 of consulting expense through the term of the agreement. On July 2, 2015 the Company issued the 500,000 17,746 On August 26, 2015, the Company issued 560,000 shares of common stock to a consultant as compensation for a six month period consulting service. The Company valued the 560,000 0.04 4,261 On September 8, 2015, the Company issued 600,000 shares of common stock to a member of the Company’s Scientific Advisory Board. The Company valued the 600,000 0.0369 Additionally, during the three months ended September 30, 2015, the Company recognized $ 281,313 On July 24, 2015, the Company entered into an agreement with a consultant to provide services over a six month period. The Company agreed to issue the consultant 8,000,000 shares of common stock. The Company valued the 8,000,000 0.0435 348,000 8,000,000 128,609 Shares issued for conversion of convertible debt On August 14, 2015, pursuant to a conversion notice, $ 20,500 0.02365 866,796 On August 14, 2015, pursuant to a conversion notice, $ 20,802 0.02365 879,585 On August 26, 2015, pursuant to a conversion notice, $ 26,068 0.018425 1,414,843 On September 1, 2015, pursuant to a conversion notice, $ 25,723 0.018425 1,396,108 On September 4, 2015, pursuant to a conversion notice, $ 15,648 0.018425 849,263 On September 16, 2015, pursuant to a conversion notice, $ 15,687 0.018975 826,726 On September 18, 2015, pursuant to a conversion notice, $ 15,694 0.017875 877,969 On September 22, 2015, pursuant to a conversion notice, $ 15,638 0.01716 911,294 Warrants: As of September 30, 2015, there were 7,379,158 warrants outstanding and exercisable with expiration dates commencing September 2018 May 2020. No warrants were granted during the three months ended September 30, 2015 | NOTE 8 STOCKHOLDERS’ DEFICIT Preferred Stock: The total number of preferred shares authorized and that may be issued by the Company is 10,000,000 0.01 Of the total preferred shares authorized, pursuant to Certificate of Designation filed on December 9, 2014, 500,000 0.01 500,000 0.00213 1,067 8,161,000 Of the total preferred shares authorized, pursuant to Certificate of Designation filed on June 16, 2015, up to five (5) shares have been designated as Series B preferred stock, with a par value of $ 0.01 0.1165 0.12 This value represents the economic rights of the share as the value of voting rights, which represent control rights, are not objectively measureable. Common Stock: On November 12, 2014, the Company filed an amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware, to increase the Company’s authorized common stock from one hundred million (100,000,000) shares of common stock, par value $ 0.001 0.001 0.001 0.001 In July 2013, the Company issued 300,000 0.20 12,000 48,000 In July 2013, the Company issued 250,000 0.20 50,000 In July 2013, the Company issued 137,500 27,500 0.20 In July 2013, the Company issued 10,000 0.20 2,000 In July 2013, the Company issued 150,000 0.20 30,000 In September 2013, the Company issued the balance of 300,000 0.20 60,000 On September 30, 2013, pursuant to a consulting agreement, the company issued 25,000 0.20 5,000 In October 2013, the Company issued 500,000 0.10 50,000 In October 2013, the Company issued 200,000 0.10 13,333 6,667 In October 2013, the Company issued 100,000 0.10 10,000 In November 2013, the Company issued 30,000 0.10 3,000 In November 2013, the Company issued 25,000 0.10 2,500 On May 9, 2014, the Company entered into an agreement with a consultant to provide services over a twelve month period in exchange for 1,000,000 0.10 100,000 500,000 500,000 100,000 On July 2, 2014, a $ 139,680 154,798 0.0709 2,183,333 On September 11, 2014, the Company issued 7,426,000 On October 17, 2014, the Company entered into an agreement with a consultant to provide services over a six month period. The Company agreed to issue the consultant 4,000,000 3,000,000 3,000,000 10,000,000 0.008 80,000 4,000,000 6,000,000 80,000 On November 4, 2014, the Company issued 8,161,000 On November 5, 2014, the Company entered into a private placement securities purchase agreement with an accredited investor pursuant to which the Company agreed to issue up to 3,000,000 0.001 3,000 3,000,000 On December 9, 2014, pursuant to a conversion notice, $ 5,357 0.0011 4,870,391 On December 10, 2014, pursuant to a conversion notice, $ 7,368 0.0011 6,698,331 On December 11, 2014, the Company entered into a private placement securities purchase agreement with an accredited investor pursuant to which the Company agreed to issue up to 1,000,000 0.0025 2,500 On December 16, 2014, the Company entered into a private placement securities purchase agreements with accredited investors pursuant to which the Company agreed to issue up to 9,400,000 0.0025 23,500 On December 16, 2014, pursuant to a conversion notice, $ 6,000 0.0012 5,194,805 On December 24, 2014, pursuant to a conversion notice, $ 3,762 0.0007 5,700,000 On December 26, 2014, pursuant to a conversion notice, $ 4,044 0.0007 5,655,958 During the year ended June 30, 2015, pursuant to the January 30, 2015 Settlement and Lock-up Agreement (Note 9), the Company issued 10,000,000 0.0025 25,000 On February 2, 2015, pursuant to a conversion notice, $ 3,446 0.0006 6,265,964 On February 4, 2015, pursuant to debt settlement agreements with two directors (Note 4), the Company issued 17,654,470 33,259,350 0.0025 44,136 83,148 On February 9, 2015, pursuant to a conversion notice, $ 21,100 0.0035 6,089,544 On February 17, 2015, pursuant to a conversion notice, $ 3,266 0.0006 5,937,563 On February 17, 2015, pursuant to a conversion notice, $ 15,323 0.0035 4,422,257 On March 6, 2015, pursuant to a conversion notice, $ 3,410 0.0006 6,200,000 On March 6, 2015, pursuant to a conversion notice, $ 6,443 0.0015 4,338,384 On March 6, 2015, pursuant to a conversion notice, $ 1,011 0.0015 680,485 On March 11, 2015, pursuant to a conversion notice, $ 14,675 0.0015 9,882,013 On March 11, 2015, pursuant to a conversion notice, $ 10,121 0.0015 6,815,185 On March 12, 2015, pursuant to a conversion notice, $ 1,001 0.0015 674,141 On March 12, 2015, pursuant to a conversion notice, $ 14,678 0.0015 9,884,155 On March 12, 2015, pursuant to a conversion notice, $ 10,125 0.0016 6,347,918 On March 16, 2015, pursuant to a conversion notice, $ 15,534 0.0017 9,110,833 On March 17, 2015, pursuant to a conversion notice, $ 1,061 0.0017 622,504 On March 17, 2015, pursuant to a conversion notice, $ 20,048 0.0019 10,414,660 On March 18, 2015, pursuant to a conversion notice, $ 20,053 0.0020 10,127,576 On March 19, 2015, pursuant to a conversion notice, $ 8,260 0.0020 4,171,808 On March 20, 2015, pursuant to a conversion notice, $ 23,762 0.0020 12,001,242 On April 14, 2015, pursuant to a conversion notice, $ 4,271 0.0020 2,135,450 On April 15, 2015, pursuant to a conversion notice, $ 10,145 0.0020 5,072,740 On April 21, 2015, pursuant to a conversion notice, $ 28,202 0.0020 14,100,870 On May 7, 2015, the Company entered into an agreement with a consultant to provide services over a six month period in exchange for 6,758,316 shares of common stock. The Company valued the 6,758,316 0.043 290,608 6,758,316 88,446 On May 21, 2015, the Company entered into an agreement with a consultant to provide services over an eight month period in exchange for 1,000,000 shares of common stock. The Company valued the 1,000,000 0.0445 44,500 1,000,000 7,265 On June 4, 2015, the Company entered into an agreement with a consultant to provide services over a six month period in exchange for 500,000 shares of common stock. The Company valued the 500,000 0.0706 35,300 500,000 5,015 Warrants: In September, 2013, pursuant to convertible debenture, the Company issued 3,000,000 0.0698 5 In connection with above agreement dated May 7, 2015, the Company issued to the consultant, warrants for 3,379,158 0.043 0.03 397 60 1.54 145,303 101,080 44,223 In connection with above agreement dated May 21, 2015, the Company issued to the consultant warrants for 1,000,000 0.0445 0.07 397 60 1.54 44,500 37,235 7,265 As of June 30, 2015, there were 7,379,158 Weighted Number of Average Shares Price Per Share Outstanding at June 30, 2013 - $ - Issued 3,000,000 0.07 Exercised - - Expired - - Outstanding at June 30, 2014 3,000,000 0.07 Issued 4,379,158 0.04 Exercised - - Expired - - Outstanding at June 30, 2015 7,379,158 $ 0.05 Exercisable at June 30, 2015 7,379,158 $ 0.05 Outstanding and Exercisable: Weighted average remaining contractual term 4.21 Aggregate intrinsic value $ 319,774 |
COMMITMENTS AND CONTINGIENCIES
COMMITMENTS AND CONTINGIENCIES | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Commitments and Contingencies Disclosure [Abstract] | ||
Commitments and Contingencies Disclosure [Text Block] | NOTE 7 COMMITMENTS AND CONTINGIENCIES Legal Matters From time to time, the Company may be involved in litigation relating to claims arising out of the Company’s operations in the normal course of business. The Company is presently in litigation with JMJ Financial Inc., a Florida corporation (“JMJ”), in the Circuit Court of Dade County, Florida. JMJ is claiming funds due under a convertible promissory note of Twenty Five thousand Dollars ($ 25,000.00 Operating Agreements In November 2009, the Company entered into a commercialization agreement whereby the Company agreed to pay royalties of 2% of net revenues. Additionally, the Company agreed to pay 5% of each and every license agreement subscribed for. The contract is cancellable at any time by either party. To date, no amounts are owed under the agreement. Operating Leases On May 1, 2015, the Company moved to new premises. On May 1, 2015, the Company entered into a month to month lease agreement with new landlord with a monthly rental fee of approximately $2,200 AUD and requiring a three month notice, by either party, to terminate agreement. Rent expense for the three months ended September 30, 2015 and 2014 were $ 4,938 2,777 | NOTE 9 COMMITMENTS AND CONTINGIENCIES Legal Matters From time to time, the Company may be involved in litigation relating to claims arising out of the Company’s operations in the normal course of business. The Company is presently in litigation with JMJ Financial Inc., a Florida corporation (“JMJ”), in the Circuit Court of Dade County, Florida. JMJ is claiming funds due under a convertible promissory note of Twenty Five thousand Dollars ($25,000.00). The Company is actively defending all allegations made by JMJ, and has lodged a counter claim against the plaintiff. The parties are currently negotiating for a possible settlement, and a mediation is expected to be scheduled in September or October 2015 to determine a settlement. The Company does not believe the result of this litigation matter will have a material adverse effect on our financial conditions or results of operations. Operating Agreements In November 2009, the Company entered into a commercialization agreement whereby the Company agreed to pay royalties of 2 5 Operating Leases From July 2013 through April 30, 2015, the Company utilized office space at a certain location. There was no formal lease agreement and no amounts were paid, but the Company had accrued a liability as of April 30, 2015 of approximately $ 21,000 1,000 2,200 Rent expense for the years ended June 30, 2015 and 2014 were $ 3,719 11,016 Settlement and Stipulation Agreement In July 2014, the Company signed a term sheet and a Settlement and Stipulation Agreement (the "Settlement Agreement") with a third party purchaser (the "purchaser") to have that purchaser acquire certain portions of the Company’s liabilities to creditors (“Creditors”) in exchange for an obligation of the Company to issue shares of common stock to the purchaser, which shares of common stock would then be sold by the purchaser and 65 Under the terms of the Settlement Agreement, the variable quantity of common stock will be issued in tranches such that the purchaser would not own more than 9.99 Under the above agreements, in May 2014 the Company also paid an expense fee of $ 25,000 The purchaser entered into agreements through July 2014 with the Creditors to acquire $ 627,998 50,000 75 1,033,000 405,000 During the year ended June 30, 2015, the Company issued a total of 15,587,000 15,587,000 52,907 575,000 310,000 67,000 Equity Purchase Agreement On July 18, 2014 the Company executed an Equity Purchase Agreement (the "agreement") with an investor (the "investor") affiliated with the above purchaser. The Company may sell (put shares) from time to time, during the commitment period discussed below, up to $ 5,000,000 90 9.99 The commitment period is the earlier of the sale of $5,000,000 worth of shares or 24 On July 18, 2014, Company entered into a Registration Rights Agreement with the investor. Pursuant to the terms of the Registration Rights Agreement, the Company is obligated to file a registration statement (the “Registration Statement”) with the SEC to cover the Registrable Securities within one hundred twenty (120) days of closing of an equity purchase. The Company must use its commercially reasonable efforts to cause the Registration Statement relating to the Registered Securities to become effective within five (5) business days after notice from the SEC that such Registration Statement may be declared effective, and keep the Registration Statement effective at all time prior to the termination of the Equity Purchase Agreement until the earliest of (i) date that is three months after the completion of the last Closing date (as defined in the Equity Purchase Agreement), (ii) the date when the investor may sell all Registered Securities under Rule 144 without volume limitations, or (iii) the date the investor no longer owns any of the Registered Securities (collectively, the “Registration Period”). On July 18, 2014 the Company paid a $ 50,000 50,000 10,000,000 50,000 25,000 1,466 0.0025 25,000 51,466 |
INCOME TAXES
INCOME TAXES | 12 Months Ended |
Jun. 30, 2015 | |
Income Tax Disclosure [Abstract] | |
Income Tax Disclosure [Text Block] | NOTE 7 INCOME TAXES The Company follows ASC 740-10-10, under which an entity recognizes deferred tax assets and liabilities for future tax consequences or for events that were previously recognized in the Company’s financial statements or tax returns. The measurement of deferred tax assets and liabilities is based on enacted tax law provisions. The effects of future changes in tax laws or rates are not anticipated. As of June 30, 2015, the Company operated exclusively in Australia. The Company was wholly subject to Australia income tax laws and regulations, which are administered by the Australian Taxation Office for the years ended June 30, 2015 and 2014 and all prior years. On November 23, 2010, Propanc Health Group Corporation was incorporated in the state of Delaware. In January 2011, Propanc Health Group Corporation acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary. As a result of these transactions, the Company is subject to the income tax laws of both the United States and Australia for the years ended June 30, 2015 and 2014. For the years ended June 30, 2015 and 2014, all the Company’s loss before income taxes resulted entirely from its Australian activities and its taxable loss was only subject to Australian tax law. At June 30, 2015, the Company has a net operating loss (NOL) for Australian tax purposes only, that approximates $ 12,486,000 1,527,228 Year Ended June 30, June 30, 2015 2014 Current Taxes $ (77,470) $ (48,267) Deferred Taxes - - Income Taxes Expense (Benefit) $ (77,470) $ (48,267) Year Ended June 30, June 30, 2015 2014 Impact on Impact on Amount Rate Amount Rate Income Tax Expense (Benefit) at Australia Statutory Rate $ (672,087) (19.26) % $ (274,229) (31.24) % Expenses Paid by Parent on Behalf of Foreign Subsidiary 156,410 4.48 % 92,480 10.54 % R&D Refundable Tax Credit (77,470) (2.22) % (48,267) (5.50) % Reduction of NOL Carryforward Due to R&D Tax Credit 77,470 2.22 % 48,267 5.50 % Change in Deferred Tax Valuation Allowance (355,636) (10.19) % 260,533 29.68 % Foreign Exchange Rate Changes 793,843 22.74 % (127,051) (14.47) % Total Income Tax Expense (Benefit) $ (77,470) (2.22) % $ (48,267) (5.50) % Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and amounts used for income tax purposes. June 30, June 30, 2015 2014 Current Deferred Tax Assets Warrant Derivative Liability $ 88,204 $ 28,209 Provision for Annual Leave 21,426 18,848 Superannuation - 3,815 Total Current Deferred Tax Assets $ 109,630 $ 50,872 Current Deferred Tax Liabilities Prepaid Investor Services $ - $ - Prepaid Expenses - - Prepaid Insurance - - Accounts Payable/Trade Creditors - - Patent Costs - - Total Current Deferred Tax Liabilities $ - $ - Non-Current Deferred Tax Assets Prepaid Investor Services $ 185,025 $ 751,917 Capital Raising Costs 23,261 28,622 Legal Costs 23,583 29,019 Intellectual Property 11,612 14,288 Patent Costs 59,995 59,473 Formation Expense 7,117 8,757 Net Operating Loss Carryover 3,426,149 3,259,060 Foreign Exchange Loss (OCI) (30,290) 90,859 Total Non-Current Deferred Tax Assets 3,706,452 4,241,995 Deferred Tax Valuation Allowance (3,816,082) (4,292,867) Total Non-Current Deferred Tax Assets (109,630) (50,872) Total Deferred Tax Assets (Net) $ - $ - Management has determined that the realization of the net deferred tax asset is not assured and has created a valuation allowance for the entire amount of such benefits. The Company follows ASC 740-10, which provides guidance for the recognition and measurement of certain tax positions in an enterprise’s financial statements. Recognition involves a determination whether it is more likely than not that a tax position will be sustained upon examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of all relevant information. The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of June 30, 2015 the Company had no unrecognized tax benefits. There were no changes in the Company’s unrecognized tax benefits during the years ended June 30, 2015 and 2014. The Company did not recognize any interest or penalties during fiscal 2015 or 2014 related to unrecognized tax benefits. The income tax returns filed for the tax years from inception will be subject to examination by the relevant taxing authorities. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Related Party Transactions [Abstract] | ||
Related Party Transactions Disclosure [Text Block] | NOTE 8 RELATED PARTY TRANSACTIONS Since inception, Propanc Health Group Corporation has conducted transactions with directors and director related entities. These transactions included the following: As of September 30, 2015 and June 30, 2015, the Company owed certain directors a total of $59,360 and $79,416 respectively, for money loaned to the Company throughout the years. The loan balance owed at September 30, 2015 was not interest bearing (See Note 4). As of September 30, 2015 and June 30 2015, the Company owed two directors a total of $31,994 and $35,108, respectively, related to expenses paid on behalf of the Company related to corporate startup costs and intellectual property (See Note 3). | NOTE 10 RELATED PARTY TRANSACTIONS Since inception, Propanc Health Group Corporation has conducted transactions with directors and director related entities. These transactions included the following: As of June 30, 2015 and June 30, 2014, the Company owed certain directors a total of $ 79,416 161,975 As of June 30, 2015 and June 30 2014, the Company owed two directors a total of $ 35,108 60,350 On February 4, 2015, the Company entered into a Debt Settlement Agreement with some of these directors whereby the Company issued 33,259,350 17,654,470 41,000 0.0025 127,284 86,455 |
CONCENTRATIONS AND RISKS
CONCENTRATIONS AND RISKS | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Risks and Uncertainties [Abstract] | ||
Concentration Risk Disclosure [Text Block] | NOTE 9 CONCENTRATIONS AND RISKS Concentration of Credit Risk The Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company has not experienced any losses in such accounts through September 30, 2015. Receivable Concentration As of September 30, 2015 and June 30, 2015, the Company’s receivables were 100 Product and Patent Concentration As of September 30, 2015 the Company was undertaking preclinical activities for their lead product. The Company was also undertaking research to uncover the mechanism of action of their lead product in order to screen new compounds for development. The Company previously expanded by the filing of an international PCT patent application (No. PCT/AU2010/001403) directed to enhanced proenzyme formulations and combination therapies. The international PCT application has been based on previous provisional patent applications capturing the Company’s ongoing research and development in this area. The Company received grant status in South Africa and more recently in Australia and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of our technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, while also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions, include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is granted in South Africa, Australia, and New Zealand. Further provisional patent filings are also expected to be filed to capture and protect additional patentable subject matter that is identified, namely further enhanced formulations, combination treatments, use of recombinant products, modes of action and molecular targets. Foreign Operations As of September 30, 2015 and June 30, 2015, the Company's operations are based in Australia. | NOTE 11 CONCENTRATIONS AND RISKS Concentration of Credit Risk The Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company has not experienced any losses in such accounts through June 30, 2015. Receivable Concentration As of June 30, 2015 and 2014, the Company’s receivables were 100 Product and Patent Concentration As of June 30, 2015 the Company was undertaking preclinical activities for their lead product. The Company was also undertaking research to uncover the mechanism of action of their lead product in order to screen new compounds for development. The Company previously expanded by the filing of an international PCT patent application (No. PCT/AU2010/001403) directed to enhanced proenzyme formulations and combination therapies. The international PCT application has been based on previous provisional patent applications capturing the Company’s ongoing research and development in this area. The Company received grant status in South Africa and more recently in Australia and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of our technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, while also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions, include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is granted in South Africa, Australia, and New Zealand. Further provisional patent filings are also expected to be filed to capture and protect additional patentable subject matter that is identified, namely further enhanced formulations, combination treatments, use of recombinant products, modes of action and molecular targets. Foreign Operations As of June 30, 2015 and 2014, the Company's operations are based in Australia. |
DERIVATIVE FINANCIAL INSTRUMENT
DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||
Derivative Instruments and Hedging Activities Disclosure [Text Block] | NOTE 10 - DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS Derivative Financial Instruments: The Company applies the provisions of ASC Topic 815-40, Contracts in Entity’s Own Equity 3,000,000 555,000 87,500 The Company calculates the estimated fair values of the liabilities for derivative instruments using the Black Scholes (“BSM”) option pricing model. The closing price of the Company’s common stock at September 30, 2015 was $ 0.0289 September 30, Volatility 216 % Expected remaining term 3 Risk-free interest rate 1.37 % Expected dividend yield none Convertible Debt Initial Valuations September 30, Volatility 408 % 414 % Expected Remaining Term 0.83 0.51 - 1.45 Risk Free Interest Rate 0.7 % 0.6 % Expected dividend yield none none Fair Value Measurements: The Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable warrants and embedded conversion options have been recorded as determined utilizing the BSM option pricing model. Balance at Quoted Prices Significant September in Active Other Significant 30, Markets for Observable Unobservable 2015 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Embedded conversion option liabilities $ 350,063 $ $ $ 350,063 Fair value of liability for warrant derivative instruments $ 86,662 $ $ $ 86,662 Total $ 436,725 $ $ $ 436,725 Fair Value of Liability for Derivative Instruments Balance at June 30, 2015 $ 1,049,929 Effects of foreign currency exchange rate changes (17,351) Initial fair value of embedded conversion option derivative liability recorded as debt discount 200,000 Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO 4,610 Change in fair value included in statements of operations (800,463) Balance at September 30, 2015 $ 436,725 | NOTE 12 - DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS Derivative Financial Instruments: The Company applies the provisions of ASC Topic 815-40, Contracts in Entity’s Own Equity 3,000,000 335,000 87,500 The Company calculates the estimated fair values of the liabilities for derivative instruments using the Black Scholes (“BSM”) option pricing model. The closing price of the Company’s common stock at June 30, 2015 was $ 0.0899 Initial Valuation September 30, 2013 June 30, 2014 June 30, 2015 Volatility 53 % 134 % 408 % Expected remaining term 5 4.25 3.25 Risk-free interest rate 0.4 % 0.47 % 1.63 % Expected dividend yield None None None Convertible Debt Initial Valuations June 30, 2015 Volatility 216 - 377 % 408 % Expected remaining term 0.83 2.00 0.82 1.70 Risk-free interest rate 0.5 0.7 % 0.64 % Expected dividend yield None None Fair Value Measurements: The Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable warrants and embedded conversion options have been recorded as determined utilizing the BSM option pricing model. Balance at Quoted Prices Significant June in Active Other Significant 30, Markets for Observable Unobservable 2015 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Embedded conversion option liabilities $ 780,281 $ $ $ 780,281 Fair value of liability for warrant derivative instruments $ 269,648 $ $ $ 269,648 Total $ 1,049,929 $ $ $ 1,049,929 Balance at Quoted Prices Significant June in Active Other Significant 30, Markets for Observable Unobservable 2014 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Fair value of liability for warrant derivative instruments $ 158,244 $ $ $ 158,244 Fair Value of Liability for Derivative Instruments Balance at June 30, 2013 $ - Effects of foreign currency exchange rate changes (2,519) Initial fair value of embedded conversion option derivative liability recorded as debt discount 144,241 Change in fair value included in statements of operations 16,522 Balance at June 30, 2014 158,244 Effects of foreign currency exchange rate changes (42,796) Initial fair value of embedded conversion option derivative liability recorded as debt discount 392,500 Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO 1,082,567 Change in fair value included in statements of operations (540,586) Balance at June 30, 2015 $ 1,049,929 |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Subsequent Events [Abstract] | ||
Subsequent Events [Text Block] | NOTE 11 SUBSEQUENT EVENTS On October 1, 2015, the Company received cash of $ 1,150,000 1,200,000 50,000 th Securities Purchase Agreement On October 28, 2015 (the “Closing Date”), the Company entered into a securities purchase agreement dated as of the Closing Date (the “Purchase Agreement”) with Delafield Investments Limited (the “Purchaser”). The Purchase Agreement provides that, upon the terms and subject to the conditions set forth therein, the Purchaser will invest $ 4,000,000 4,400,000 26,190,476 0.001 0.60 Under the terms of the Purchase Agreement, the Purchaser agreed to deliver the Promissory Note entered into by the Company and Purchaser on September 24, 2015 with a principal amount of $ 1,200,000 Under the terms of the Purchase Agreement and Debenture, $ 2,800,000 25,000 25,000 The Purchase Agreement contains customary representations, warranties and covenants by, among and for the benefit of the parties. The Company also agreed to pay up to $ 50,000 Debenture The Debenture has a 10 5 The Debenture includes customary event of default provisions, and provides for a default interest rate of 18 30 Subject to the conditions set forth in the Debenture, the Company has the right at any time to redeem some or all of the total outstanding amount then remaining under the Debenture in cash at a price equal to 125 Warrant The Warrants are exercisable in whole or in part, at an initial exercise price per share of $ 0.60 Registration Rights Agreement In connection with the execution of the Purchase Agreement, on the Closing Date, the Company and the Purchaser also entered into a registration rights agreement dated as of the Closing Date (the “Registration Rights Agreement”). Pursuant to the Registration Rights Agreement, the Company has agreed to file an initial registration statement (“Registration Statement”) with the SEC to register the resale of the Common Stock into which the Debenture may be converted or the Warrant may be exercised, within 30 days following the Closing Date. The Registration Statement must also be declared effective by the 100th calendar day after the Closing Date, subject to a 20-day extension as requested by the Company and consented to by the Purchaser. If at any time all of the shares of Common Stock underlying the Debenture or the Warrant are not covered by the initial Registration Statement, the Company has agreed to file with the SEC one or more additional Registration Statements so as to cover all of the shares of Common Stock underlying the Debenture or the Warrant not covered by such initial Registration Statement, in each case, as soon as practicable, but in no event later than the applicable filing deadline for such additional Registration Statements as provided in the Registration Rights Agreement. Security Agreement In connection with the Purchase Agreement, the Company entered into a Security Agreement dated as of even date therewith with the Purchaser whereby the Company agreed to grant to Purchaser an unconditional and continuing, first priority security interest in all of the assets and property of the Company to secure the prompt payment, performance and discharge in full of all of Company’s obligations under the Debentures, Warrants and the other transaction documents until ten days following the such time as the Registration Statement is declared effective by the SEC and the equity conditions set forth in the Debenture are met. Shares issued for conversion of convertible debt On October 1, 2015, pursuant to a conversion notice, $ 26,635 0.012375 2,152,289 On October 7, 2015, pursuant to a conversion notice, $ 31,374 0.012375 2,535,293 On October 13, 2015, pursuant to a conversion notice, $ 109,004 0.012375 8,808,435 On October 13, 2015, pursuant to a conversion notice, $ 104,712 0.012375 8,461,602 On October 15, 2015, pursuant to a conversion notice, $ 50,000 0.01 5,000,000 Shares issued for services On October 1, 2015, the Company entered into an agreement with a consultant to provide services over a one year period. The Company agreed to issue the consultant 1,500,000 1,500,000 0.031 46,500 On October 1, 2015, the Company issued 1,100,000 On October 1, 2015, the Company issued 400,000 On October 8, 2015, the Company issued 8,000,000 On October 16, 2015, the Company issued 4,000,000 0.0415 166,000 | NOTE 13 SUBSEQUENT EVENTS Subsequent to June 30, 2015, the Company received payment of the Secured Investor Note of $ 220,000 20,000 1,997 201,997 0.07 (See Note 6). On July 14, 2015, the Company received payment of three Note Receivables of $ 352,500 17,690 334,810 (See Note 6). On July 15, 2015, the Company paid cash of $ 137,915 104,000 2,872 31,043 On August 14, 2015, pursuant to a conversion notice, $ 20,500 0.02365 866,796 On August 14, 2015, pursuant to a conversion notice, $ 20,802 0.02365 879,585 On August 26, 2015, pursuant to a conversion notice, $ 26,068 0.018425 1,414,843 On August 26, 2015, the Company issued 560,000 0.04 On September 1, 2015, pursuant to a conversion notice, $ 25,723 0.018425 1,396,108 On September 4, 2015, pursuant to a conversion notice, $ 15,648 0.018425 849,263 On September 8, 2015, the Company issued 600,000 0.0369 On September 16, 2015, pursuant to a conversion notice, $ 15,687 0.018975 826,726 On September 18, 2015, pursuant to a conversion notice, $ 15,694 0.017875 877,969 On September 22, 2015, pursuant to a conversion notice, $ 15,638 0.01716 911,294 On September 24, 2015 1,200,000 1,200,000 The debenture has a maturity date of the earlier of: (i) the date on which the Company closes a subsequent equity offering in an amount greater than the principal amount of the Note; or (ii) June 24, 2016. th 180,000 0.0346 20 |
NATURE OF OPERATIONS AND SUMM21
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Policies) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Accounting Policies [Abstract] | ||
Nature of Operations, Policy [Policy Text Block] | Nature of Operations Propanc PTY LTD was incorporated in Melbourne, Victoria Australia on October 15, 2007, and is based in Richmond, Victoria Australia. Since inception, substantially all of the efforts of the Company have been the development of new cancer treatments targeting high risk patients who need a follow up, nontoxic, long term therapy which prevents the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. On November 23, 2010, Propanc Health Group Corporation ("the Company", "we", "us", "our") was incorporated in the state of Delaware. In January 2011, to reorganize the Company, Propanc Health Group Corporation acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary. | Nature of Operations Propanc PTY LTD was incorporated in Melbourne, Victoria Australia on October 15, 2007, and is based in Richmond, Victoria Australia. Since inception, substantially all of the efforts of the Company have been the development of new cancer treatments targeting high risk patients who need a follow up, nontoxic, long term therapy which prevents the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. On November 23, 2010, Propanc Health Group Corporation ("the Company", "we", "us", "our") was incorporated in the state of Delaware. In January 2011, to reorganize the Company, Propanc Health Group Corporation acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary. |
Basis of Accounting, Policy [Policy Text Block] | Basis of Presentation The interim unaudited consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our results of operations and cash flows for the three months ended September 30, 2015 and 2014 and our financial position as of September 30, 2015 have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year. Certain information and disclosures normally included in the notes to the annual audited consolidated financial statements have been condensed or omitted from these interim unaudited consolidated financial statements. Accordingly, these interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2015. The June 30, 2015 balance sheet is derived from those statements. | |
Consolidation, Policy [Policy Text Block] | Principals of Consolidation The unaudited consolidated financial statements include the accounts of Propanc Health Group Corporation and its wholly-owned subsidiary, Propanc PTY LTD. All significant inter-company balances and transactions have been eliminated in consolidation. | Principals of Consolidation The consolidated financial statements include the accounts of Propanc Health Group Corporation and its wholly-owned subsidiary, Propanc PTY LTD. All significant inter-company balances and transactions have been eliminated in consolidation. |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying unaudited consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates. | Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates. |
Foreign Currency Transactions and Translations Policy [Policy Text Block] | Foreign Currency Translation and Comprehensive Income (Loss) The Company’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into United States dollars ($) and/or USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the statements of operations and other comprehensive income (loss) as other income (expense). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Comprehensive income (loss) for all periods presented, includes only foreign currency translation gains (losses). Changes in Accumulated Other Comprehensive Income (Loss) by Component during the three months ended September 30, 2015 was as follows: Foreign Beginning balance, June 30, 2015 $ 100,968 Foreign currency translation gain 258,430 Ending balance, September 30, 2015 $ 359,398 | Foreign Currency Translation and Comprehensive Income (Loss) The Company’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into United States dollars ($) and/or USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the statement of operations and comprehensive loss as other income (expense). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Comprehensive income (loss) for all periods presented, includes only foreign currency translation gains (losses). Foreign Currency Items: Beginning balance, June 30, 2013 $ (244,589) Foreign currency translation loss (58,274) Balance, June 30, 2014 (302,863) Foreign currency translation gain 403,831 Ending balance, June 30, 2015 $ 100,968 |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair Value of Financial Instruments and Fair Value Measurements The Company measures their financial assets and liabilities in accordance with US GAAP. For certain of the Company’s financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued expenses and other liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for loans payable, also approximate fair value because current interest rates available to us for debt with similar terms and maturities are substantially the same. The Company adopted accounting guidance for fair value measurements of financial assets and liabilities. The adoption did not have a material impact on the Company’s results of operations, financial position or liquidity. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. | Fair Value of Financial Instruments and Fair Value Measurements The Company measures their financial assets and liabilities in accordance with US GAAP. For certain of the Company’s financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued expenses and other liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for loans payable, also approximate fair value because current interest rates available to us for debt with similar terms and maturities are substantially the same. The Company adopted accounting guidance for fair value measurements of financial assets and liabilities. The adoption did not have a material impact on the Company’s results of operations, financial position or liquidity. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and Cash Equivalents Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were no cash equivalents as of September 30, 2015 or June 30, 2015. | Cash and Cash Equivalents Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were no cash equivalents as of June 30, 2015 or 2014. |
Receivables, Policy [Policy Text Block] | Receivables As amounts become uncollectible, they will be charged to an allowance and operations in the period when a determination of uncollectability is made. Any estimates of potentially uncollectible customer accounts receivable will be made based on an analysis of individual customer and historical write-off experience. The Company’s analysis included the age of the receivable account, creditworthiness of the customer and general economic conditions. | |
Property, Plant and Equipment, Policy [Policy Text Block] | Property, Plant, and Equipment Property and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred; additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value. The estimated useful lives are as follows: Machinery and equipment 5 | |
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] | Patents Patent costs are stated at cost and reclassified to intangible assets and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency, however, the Company will expense any costs as long as the Company is in the startup stage. Accordingly, as the Company's product was and is not currently approved for market, thus any patent costs incurred from 2013 through 2015 were expensed immediately. Currently, the Company has one International patent pending which was jointly applied for by the Company and another entity. The Company received grant status, or has been accepted in South Africa, Australia, and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of the Company’s technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, whilst also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions where the Company is actively seeking patent protection include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is now granted, or accepted in South Africa, Australia, and New Zealand. | Patents Patent costs are stated at cost and reclassified to intangible assets and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency, however, the Company will expense any costs as long as the Company is in the startup stage. Accordingly, as the Company's product was and is not currently approved for market, thus any patent costs incurred from 2013 through 2015 were expensed immediately. Currently, the Company has one International patent pending which was jointly applied for by the Company and another entity. The Company received grant status , or been accepted in South Africa, Australia, and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of the Company’s technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, whilst also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions where the Company is actively seeking patent protection include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is now granted , or accepted in South Africa, Australia, and New Zealand. |
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] | Impairment of Long-Lived Assets In accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. | Impairment of Long-Lived Assets In accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. |
Compensation Related Costs, Policy [Policy Text Block] | Employee Benefit/Liability Liabilities arising in respect of wages and salaries, annual leave, accumulated sick leave and any other employee benefits expected to be settled within twelve months of the reporting date are measured at their nominal amounts based on remuneration rates which are expected to be paid when the liability is settled. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve months and therefore, recorded at nominal value. | |
Goods And Service Tax [Policy Text Block] | Australian Goods and Services Tax (GST) Revenues, expenses and balance sheet items are recognized net of the amount of GST except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office. Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows. As of September 30, 2015 and June 30, 2015 the Company was owed $15,109 and $11,647 from the Australian Taxation Office. These amounts were fully collected subsequent to the balance sheet reporting dates. | Australian Goods and Services Tax (GST) Revenues, expenses and balance sheet items are recognized net of the amount of GST except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office. Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows. As of June 30, 2015 and June 30, 2014 the Company was owed $ 11,647 946 |
Derivatives, Policy [Policy Text Block] | Derivative Instruments ASC Topic 815, Derivatives and Hedging | Derivative Instruments ASC Topic 815, Derivatives and Hedging |
Convertible Notes [Policy Text Block] | Convertible Notes With Variable Conversion Options The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480 and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion, and records the put premium as accretion to interest expense to the date of first conversion. | Convertible Notes With Variable Conversion Options The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480 and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion, and records the put premium as accretion to interest expense to the date of first conversion. |
Income Tax, Policy [Policy Text Block] | Income Taxes The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The Company adopted provisions of ASC 740, Sections 25 through 60, “Accounting for Uncertainty in Income Taxes." These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods. | Income Taxes The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The Company adopted provisions of ASC 740, Sections 25 through 60, “Accounting for Uncertainty in Income Taxes." These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods. Upon the adoption of ASC 740, the Company had no unrecognized tax benefits. During the years ended June 30, 2015 and 2014 no adjustments were recognized for uncertain tax benefits. The years 2008 through 2015 are subject to examination by the Australian Taxation Office. The years ended June 30, 2012 through 2015 is subject to examination by the United States Internal Revenue Service. |
Research and Development Expense, Policy [Policy Text Block] | Research and Development Costs and Tax Credits In accordance with ASC 730-10, research and development costs are expensed when incurred. Total research and development costs for the three months ended September 30, 2015 and 2014 were $153,474 and $3,879 respectively. The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income then the Company can receive the credit which reduces its income tax liability. If the Company has net losses then the Company may still receive a cash payment for the credit, however, the Company's net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as an income tax benefit, in operations, upon receipt. | Research and Development Costs and Tax Credits In accordance with ASC 730-10, research and development costs are expensed when incurred. Total research and development costs for the years ended June 30, 2015 and 2014 were $ 134,319 8,168 The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income then the Company can receive the credit which reduces its income tax liability. If the Company has net losses then the Company may still receive a cash payment for the credit, however, the Company's net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as an income tax benefit, in operations, upon receipt. During the years ended June 30, 2015 and 2014, the Company applied for and received from the Australian Taxation Office a research and development tax credit in the amount of $ 77,470 48,267 |
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] | Stock Based Compensation The Company records stock based compensation in accordance with ASC section 718, “Stock Compensation” and Staff Accounting Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes Option Pricing Model. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50 “Equity-Based Payments to Non-Employees”. | Stock Based Compensation The Company records stock based compensation in accordance with ASC section 718, “Stock Compensation” and Staff Accounting Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes Option Pricing Model. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50 “Equity-Based Payments to Non-Employees”. |
Revenue Recognition, Policy [Policy Text Block] | Revenue Recognition In accordance with SEC Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition | Revenue Recognition In accordance with SEC Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition, |
Start-up Activities, Cost Policy [Policy Text Block] | Start-up Costs In accordance with ASC 720-15-15, start-up costs are expensed as incurred. | |
Earnings Per Share, Policy [Policy Text Block] | Basic and Diluted Net Loss Per Common Share Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. For the three months ended September 30 2015 and 2014, there were 7,379,158 and 3,000,000 warrants respectively outstanding and fourteen and four convertible notes payable that are convertible into 228,300,369 and 18,823,721 common shares respectively which are considered dilutive securities which were excluded from the computation since the effect is anti-dilutive. | Basic and Diluted Net Loss Per Common Share Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. For the years ended June 30 2015 and 2014, there were 7,379,158 3,000,000 335,716,597 6,069,667 |
New Accounting Pronouncements, Policy [Policy Text Block] | Recently Adopted Accounting Pronouncements Financial Accounting Standards Board, Accounting Standard Updates which are not effective until after September 30, 2015 are not expected to have a significant effect on the Company’s consolidated financial position or results of operations. The Company is evaluating the following at September 30, 2015: In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements Going Concern (Topic 205-40)”, which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard will be effective for the Company for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company expects to adopt this new standard as of December 31, 2016. The Company does not expect this ASU to have a material impact on its consolidated financial statements. On May 8, 2015, the FASB issued ASU 2015-08, “Business Combinations (Topic 805) Pushdown Accounting In April 2015, the Financial Accounting Standards Board issued Accounting Standards Update No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs," | Recently Adopted Accounting Pronouncements Financial Accounting Standards Board, Accounting Standard Updates which are not effective until after June 30, 2015 are not expected to have a significant effect on the Company’s consolidated financial position or results of operations. The Company implemented the following at June 30, 2015: In June 2014, the FASB issued ASU No. 2014-10, which amended Accounting Standards Codification (ASC) Topic 915 Development Stage Entities. The amendment eliminates certain financial reporting requirements surrounding development stage entities, including an amendment to the variable interest entities guidance in ASC Topic 810, Consolidation. The amendment removes the definition of a development stage entity from the ASC, thereby removing the financial reporting distinction between development stage entities and other entities from U.S. GAAP. Consequently, the amendment eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. This amendment is effective for fiscal years beginning after December 15, 2014, and interim periods therein. Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued. The Company has made the election to early adopt this amendment effective June 30, 2014 and, as a result, the Company is no longer presenting or disclosing the information previously required under Topic 915. The early adoption was made to reduce data maintenance by removing all incremental financial reporting requirements for development stage entities. The adoption of this amendment alters the disclosure requirements of the Company, but it does not have any material impact on the Company's financial position or results of operations for the current or any prior reporting periods. In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements Going Concern (Topic 205-40)”, which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard will be effective for the Company for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company expects to adopt this new standard as of December 31, 2015. The Company does not expect this ASU to have a material impact on its consolidated financial statements. On May 8, 2015, the FASB issued ASU 2015-08, “Business Combinations (Topic 805) Pushdown Accounting In April 2015, the Financial Accounting Standards Board issued Accounting Standards Update No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs," |
NATURE OF OPERATIONS AND SUMM22
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Accounting Policies [Abstract] | ||
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] | Changes in Accumulated Other Comprehensive Income (Loss) by Component during the three months ended September 30, 2015 was as follows: Foreign Beginning balance, June 30, 2015 $ 100,968 Foreign currency translation gain 258,430 Ending balance, September 30, 2015 $ 359,398 | Changes in Accumulated Other Comprehensive Income (Loss) by component during the years ended June 30, 2015 and 2014 were as follows: Foreign Currency Items: Beginning balance, June 30, 2013 $ (244,589) Foreign currency translation loss (58,274) Balance, June 30, 2014 (302,863) Foreign currency translation gain 403,831 Ending balance, June 30, 2015 $ 100,968 |
PROPERTY AND EQUIPMENT (Tables)
PROPERTY AND EQUIPMENT (Tables) | 12 Months Ended |
Jun. 30, 2015 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment [Table Text Block] | Property, plant, and equipment consist of the following as of June 30, 2015 2014 Office equipment at cost $ 15,732 $ 14,968 Less: Accumulated depreciation (12,238) (14,968) Total property, plant, and equipment $ 3,494 $ - |
CONVERTIBLE NOTES (Tables)
CONVERTIBLE NOTES (Tables) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Debt Disclosure [Abstract] | ||
Schedule of convertible debenture [Table Text Block] | Convertible notes at September 30, 2015 were as follows: Convertible notes and debenture $ 1,773,500 Unamortized discounts (448,532) Accrued interest 57,295 Premium 766,637 Convertible notes, net $ 2,148,900 | Convertible notes at June 30, 2015 and 2014 were as follows: June 30, 2015 June 30, 2014 Convertible notes and debenture $ 1,455,000 $ 366,296 Unamortized discounts (415,467) (121,059) Accrued interest 26,989 - Premium, net 727,853 27,187 Convertible notes, net $ 1,794,375 $ 272,424 |
STOCKHOLDERS' DEFICIT (Tables)
STOCKHOLDERS' DEFICIT (Tables) | 12 Months Ended |
Jun. 30, 2015 | |
Stockholders' Equity Note [Abstract] | |
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | The following table summarizes warrant activity for the years ended June 30, 2015 and 2014: Weighted Number of Average Shares Price Per Share Outstanding at June 30, 2013 - $ - Issued 3,000,000 0.07 Exercised - - Expired - - Outstanding at June 30, 2014 3,000,000 0.07 Issued 4,379,158 0.04 Exercised - - Expired - - Outstanding at June 30, 2015 7,379,158 $ 0.05 Exercisable at June 30, 2015 7,379,158 $ 0.05 Outstanding and Exercisable: Weighted average remaining contractual term 4.21 Aggregate intrinsic value $ 319,774 |
INCOME TAXES (Tables)
INCOME TAXES (Tables) | 12 Months Ended |
Jun. 30, 2015 | |
Income Tax Disclosure [Abstract] | |
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] | The components for the provision for income taxes are as follows: Year Ended June 30, June 30, 2015 2014 Current Taxes $ (77,470) $ (48,267) Deferred Taxes - - Income Taxes Expense (Benefit) $ (77,470) $ (48,267) |
Schedule Of Differences Between Income Taxes And Provision For Income Taxes [Table Text Block] | The items accounting for the difference between income taxes at the Australia statutory rate and the provision for income taxes are as follows: Year Ended June 30, June 30, 2015 2014 Impact on Impact on Amount Rate Amount Rate Income Tax Expense (Benefit) at Australia Statutory Rate $ (672,087) (19.26) % $ (274,229) (31.24) % Expenses Paid by Parent on Behalf of Foreign Subsidiary 156,410 4.48 % 92,480 10.54 % R&D Refundable Tax Credit (77,470) (2.22) % (48,267) (5.50) % Reduction of NOL Carryforward Due to R&D Tax Credit 77,470 2.22 % 48,267 5.50 % Change in Deferred Tax Valuation Allowance (355,636) (10.19) % 260,533 29.68 % Foreign Exchange Rate Changes 793,843 22.74 % (127,051) (14.47) % Total Income Tax Expense (Benefit) $ (77,470) (2.22) % $ (48,267) (5.50) % |
Schedule Of Deferred Income Taxes [Table Text Block] | Significant components of the Company's net deferred income taxes are as follows: June 30, June 30, 2015 2014 Current Deferred Tax Assets Warrant Derivative Liability $ 88,204 $ 28,209 Provision for Annual Leave 21,426 18,848 Superannuation - 3,815 Total Current Deferred Tax Assets $ 109,630 $ 50,872 Current Deferred Tax Liabilities Prepaid Investor Services $ - $ - Prepaid Expenses - - Prepaid Insurance - - Accounts Payable/Trade Creditors - - Patent Costs - - Total Current Deferred Tax Liabilities $ - $ - Non-Current Deferred Tax Assets Prepaid Investor Services $ 185,025 $ 751,917 Capital Raising Costs 23,261 28,622 Legal Costs 23,583 29,019 Intellectual Property 11,612 14,288 Patent Costs 59,995 59,473 Formation Expense 7,117 8,757 Net Operating Loss Carryover 3,426,149 3,259,060 Foreign Exchange Loss (OCI) (30,290) 90,859 Total Non-Current Deferred Tax Assets 3,706,452 4,241,995 Deferred Tax Valuation Allowance (3,816,082) (4,292,867) Total Non-Current Deferred Tax Assets (109,630) (50,872) Total Deferred Tax Assets (Net) $ - $ - |
DERIVATIVE FINANCIAL INSTRUME27
DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Tables) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2015 | Jun. 30, 2015 | |
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block] | Warrants September 30, Volatility 216 % Expected remaining term 3 Risk-free interest rate 1.37 % Expected dividend yield none Convertible Debt Initial Valuations September 30, Volatility 408 % 414 % Expected Remaining Term 0.83 0.51 - 1.45 Risk Free Interest Rate 0.7 % 0.6 % Expected dividend yield none none | Warrants Initial Valuation September 30, 2013 June 30, 2014 June 30, 2015 Volatility 53 % 134 % 408 % Expected remaining term 5 4.25 3.25 Risk-free interest rate 0.4 % 0.47 % 1.63 % Expected dividend yield None None None Convertible Debt Initial Valuations June 30, 2015 Volatility 216 - 377 % 408 % Expected remaining term 0.83 2.00 0.82 1.70 Risk-free interest rate 0.5 0.7 % 0.64 % Expected dividend yield None None |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2015: Balance at Quoted Prices Significant September in Active Other Significant 30, Markets for Observable Unobservable 2015 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Embedded conversion option liabilities $ 350,063 $ $ $ 350,063 Fair value of liability for warrant derivative instruments $ 86,662 $ $ $ 86,662 Total $ 436,725 $ $ $ 436,725 | The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2015 and 2014: Balance at Quoted Prices Significant June in Active Other Significant 30, Markets for Observable Unobservable 2015 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Embedded conversion option liabilities $ 780,281 $ $ $ 780,281 Fair value of liability for warrant derivative instruments $ 269,648 $ $ $ 269,648 Total $ 1,049,929 $ $ $ 1,049,929 The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2014: Balance at Quoted Prices Significant June in Active Other Significant 30, Markets for Observable Unobservable 2014 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Fair value of liability for warrant derivative instruments $ 158,244 $ $ $ 158,244 |
Schedule of Derivative Liabilities at Fair Value [Table Text Block] | The following is a roll forward for the three months ended September 30, 2015 of the fair value liability of price adjustable derivative instruments: Fair Value of Liability for Derivative Instruments Balance at June 30, 2015 $ 1,049,929 Effects of foreign currency exchange rate changes (17,351) Initial fair value of embedded conversion option derivative liability recorded as debt discount 200,000 Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO 4,610 Change in fair value included in statements of operations (800,463) Balance at September 30, 2015 $ 436,725 | The following is a roll forward for the years ended June 30, 2015 and 2014 of the fair value liability of price adjustable derivative instruments: Fair Value of Liability for Derivative Instruments Balance at June 30, 2013 $ - Effects of foreign currency exchange rate changes (2,519) Initial fair value of embedded conversion option derivative liability recorded as debt discount 144,241 Change in fair value included in statements of operations 16,522 Balance at June 30, 2014 158,244 Effects of foreign currency exchange rate changes (42,796) Initial fair value of embedded conversion option derivative liability recorded as debt discount 392,500 Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO 1,082,567 Change in fair value included in statements of operations (540,586) Balance at June 30, 2015 $ 1,049,929 |
NATURE OF OPERATIONS AND SUMM28
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2015 | Sep. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Beginning balance | $ 100,968 | $ (302,863) | $ (302,863) | $ (244,589) |
Foreign currency translation gain | 258,430 | $ 114,817 | 403,831 | (58,274) |
Ending balance | $ 359,398 | $ 100,968 | $ (302,863) |
NATURE OF OPERATIONS AND SUMM29
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details Textual) - USD ($) | 3 Months Ended | 12 Months Ended | |||
Sep. 30, 2015 | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
GST tax receivable | $ 15,109 | $ 11,647 | $ 946 | ||
Income Tax Expense (Benefit) | 0 | $ 0 | 77,470 | 48,267 | |
Research and development | $ 153,474 | $ 3,879 | $ 3,879 | $ 134,319 | $ 8,168 |
Common Stock [Member] | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 228,300,369 | 18,823,721 | 335,716,597 | 6,069,667 | |
Warrant [Member] | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 7,379,158 | 3,000,000 | 7,379,158 | 3,000,000 | |
Machinery and Equipment [Member] | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Property, Plant and Equipment, Useful Life | 5 years |
GOING CONCERN (Details Textual)
GOING CONCERN (Details Textual) - USD ($) | 3 Months Ended | 12 Months Ended | |||
Sep. 30, 2015 | Sep. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2013 | |
Going Concern [Line Items] | |||||
Net loss | $ (838,894) | $ (783,300) | $ (3,412,754) | $ (829,564) | |
Net Cash Used In Operating Activities | 627,235 | $ 99,810 | 1,426,479 | 226,442 | |
Stockholders Equity | (3,182,344) | (3,053,516) | (1,408,314) | $ (792,476) | |
Working Capital Deficit | 3,187,551 | 3,058,694 | |||
Retained Earnings (Accumulated Deficit) | $ (21,804,565) | $ (20,965,671) | $ (17,552,917) |
DUE TO DIRECTORS - RELATED PA31
DUE TO DIRECTORS - RELATED PARTIES (Details Textual) - USD ($) | Feb. 04, 2015 | Jul. 02, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | Sep. 30, 2015 | Jan. 30, 2015 |
Related Party Transaction [Line Items] | ||||||
Due to Related Parties, Current | $ 35,108 | $ 60,350 | $ 31,994 | |||
Decrease In Liability Due To Director | 44,000 | |||||
Increase In The Liability Part Of Settlement Agreement | $ 44,000 | |||||
Debt Conversion, Converted Instrument, Amount | $ 139,680 | $ 152,285 | $ 0 | |||
Director [Member] | ||||||
Related Party Transaction [Line Items] | ||||||
Debt Conversion, Converted Instrument, Amount | $ 14,000 |
PROPERTY AND EQUIPMENT (Details
PROPERTY AND EQUIPMENT (Details) - USD ($) | Sep. 30, 2015 | Jun. 30, 2015 | Jun. 30, 2014 |
Property, Plant and Equipment [Line Items] | |||
Office equipment at cost | $ 15,732 | $ 14,968 | |
Less: Accumulated depreciation | (12,238) | (14,968) | |
Total property, plant, and equipment | $ 3,672 | $ 3,494 | $ 0 |
PROPERTY AND EQUIPMENT (Detai33
PROPERTY AND EQUIPMENT (Details Textual) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2015 | Sep. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Property, Plant and Equipment [Line Items] | ||||
Depreciation expense | $ 171 | $ 0 | $ 81 | $ 538 |
LOANS (Details Textual)
LOANS (Details Textual) | 3 Months Ended | 12 Months Ended | |||
Sep. 30, 2015USD ($) | Sep. 30, 2015AUD | Sep. 30, 2014USD ($) | Jun. 30, 2015USD ($) | Jun. 30, 2014USD ($) | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Repayments of Related Party Debt | $ 13,549 | AUD 18,652 | |||
Notes Payable, Current | 6,278 | $ 27,558 | $ 33,909 | ||
Repayments of Other Debt | 19,613 | AUD 27,000 | $ 0 | ||
Foreign Currency Transaction Gain (Loss), Unrealized | 10,784 | $ 0 | (31,548) | 0 | |
Directors and Officer [Member] | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Long-term Debt, Gross | $ 59,360 | $ 79,416 | $ 161,975 |
CONVERTIBLE NOTES (Details)
CONVERTIBLE NOTES (Details) - USD ($) | Sep. 30, 2015 | Jun. 30, 2015 | Jun. 30, 2014 |
Debt Instrument [Line Items] | |||
Unamortized discounts | $ (30,000) | ||
Convertible Notes Payable [Member] | |||
Debt Instrument [Line Items] | |||
Convertible notes and debenture | $ 1,773,500 | $ 1,455,000 | 366,296 |
Unamortized discounts | (448,532) | (415,467) | (121,059) |
Accrued interest | 57,295 | 26,989 | 0 |
Premium, net | 766,637 | 727,853 | 27,187 |
Convertible notes, net | $ 2,148,900 | $ 1,794,375 | $ 272,424 |
CONVERTIBLE NOTES (Details Text
CONVERTIBLE NOTES (Details Textual) | Jul. 15, 2015USD ($) | Mar. 12, 2015USD ($) | Dec. 10, 2014USD ($) | Jul. 02, 2014USD ($)$ / sharesshares | May. 19, 2015 | Mar. 20, 2015 | Mar. 12, 2015USD ($) | Feb. 20, 2015USD ($) | Feb. 17, 2015 | Feb. 10, 2015 | Jan. 30, 2015USD ($) | Nov. 17, 2014USD ($) | Aug. 06, 2014USD ($)$ / shares | May. 30, 2014USD ($) | May. 29, 2014USD ($) | Sep. 30, 2013USD ($)$ / sharesshares | Sep. 30, 2015USD ($)$ / shares | Sep. 30, 2014USD ($) | Sep. 30, 2013USD ($)$ / shares | Jun. 30, 2015USD ($)$ / shares | Jun. 30, 2014USD ($) | Jun. 30, 2013USD ($) | Jun. 04, 2015$ / shares | Jul. 02, 2014AUD / shares | May. 08, 2014USD ($) | Sep. 30, 2013AUDAUD / shares |
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | $ 6,026 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 0.0709 | $ 0.07 | ||||||||||||||||||||||||
Share Price | $ / shares | $ 0.0289 | $ 0.0899 | ||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 30,000 | |||||||||||||||||||||||||
DerivativeLiabilities | $ 436,725 | $ 1,049,929 | 158,244 | $ 0 | ||||||||||||||||||||||
Discounts related to warrants issued with convertible debenture | $ 0 | $ 133,095 | ||||||||||||||||||||||||
Debt Instrument, Periodic Payment | $ 154,798 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||||
August 2013 Notes [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Notes Payable | $ 63,196 | $ 63,196 | ||||||||||||||||||||||||
September 2013 Notes [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Notes Payable | 46,446 | $ 46,446 | ||||||||||||||||||||||||
Warrant [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Fair Value Assumptions, Expected Volatility Rate | 216.00% | 53.00% | 408.00% | 134.00% | ||||||||||||||||||||||
Fair Value Assumptions, Expected Term | 3 years | 5 years | 3 years 3 months | 4 years 3 months | ||||||||||||||||||||||
Fair Value Assumptions, Risk Free Interest Rate | 1.37% | 0.40% | 1.63% | 0.47% | ||||||||||||||||||||||
Convertible Notes Payable [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 25,000 | $ 250,000 | $ 139,680 | $ 139,680 | $ 25,000 | AUD 150,000 | ||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | 12.00% | 10.00% | 12.00% | ||||||||||||||||||||||
Debt Instrument, Convertible, If-converted Value in Excess of Principal | $ 27,963 | |||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | $ 15,118 | $ 1,466 | $ 2,134 | |||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | (per share) | $ 0.0709 | AUD 0.075 | AUD 0.075 | |||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 25,000 | |||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues | shares | 2,183,333 | |||||||||||||||||||||||||
Debt Instrument, Debt Default, Interest Rate | 16.00% | |||||||||||||||||||||||||
Discounts related to warrants issued with convertible debenture | $ 139,680 | |||||||||||||||||||||||||
Percentage of Consideration Received | 10.00% | |||||||||||||||||||||||||
Interest Rate on Payment of Consideration | 0.00% | |||||||||||||||||||||||||
Debt Instrument, Interest Rate During Period | 12.00% | |||||||||||||||||||||||||
Debt Instrument, Periodic Payment | $ 25,000 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 60.00% | 12.00% | ||||||||||||||||||||||||
Debt Instrument, Convertible, Stock Price Trigger | $ / shares | $ 0.09 | |||||||||||||||||||||||||
Interest Payable | $ 250,000 | |||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 25,000 | |||||||||||||||||||||||||
Debt Issuance Cost | 2,500 | |||||||||||||||||||||||||
Convertible Notes Payable [Member] | Warrant [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 3,000,000 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | (per share) | $ 0.0698 | $ 0.0698 | AUD 0.075 | |||||||||||||||||||||||
Share Price | $ / shares | $ 0.20 | $ 0.20 | ||||||||||||||||||||||||
Fair Value Assumptions, Expected Volatility Rate | 53.00% | |||||||||||||||||||||||||
Fair Value Assumptions, Expected Term | 27 months | |||||||||||||||||||||||||
Fair Value Assumptions, Risk Free Interest Rate | 0.40% | |||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 400,000 | $ 400,000 | ||||||||||||||||||||||||
DerivativeLiabilities | 140,000 | $ 140,000 | ||||||||||||||||||||||||
Increase Decrease In Derivative Liabilities | $ 260,000 | |||||||||||||||||||||||||
Convertible Notes Payable One [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Face Amount | 250,000 | $ 75,000 | 60,453 | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||||||||||||||||
Debt Instrument, Maturity Date | May 29, 2015 | |||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | $ 2,965 | |||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 25,000 | $ 61,364 | ||||||||||||||||||||||||
Debt Instrument, Convertible, Terms of Conversion Feature | The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is February 10, 2016. The note is convertible at the option of the holder at any time after 180 days at a rate of 55% of the lowest trading bid price of the Companys common stock for the ten prior trading days prior to the date upon which the conversion notice was received. | |||||||||||||||||||||||||
Percentage of Consideration Received | 10.00% | |||||||||||||||||||||||||
Interest Rate on Payment of Consideration | 0.00% | |||||||||||||||||||||||||
Debt Instrument, Interest Rate During Period | 12.00% | |||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||||
Interest and Debt Expense | 51,089 | $ 10,275 | ||||||||||||||||||||||||
Debt Instrument, Periodic Payment, Principal | 14,547 | |||||||||||||||||||||||||
Debt Instrument, Periodic Payment, Interest | 218 | |||||||||||||||||||||||||
Additionally Debt Instrument Unamortized Premium | 61,364 | |||||||||||||||||||||||||
Convertible Notes Payable One [Member] | Third Party [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 4,352 | |||||||||||||||||||||||||
Convertible Notes Payable Two [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 75,000 | 63,245 | ||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||||||||||||||||
Debt Instrument, Maturity Date | May 29, 2015 | |||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 61,364 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Terms of Conversion Feature | The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is February 17, 2016. The note is convertible at the option of the holder at any time after 180 days at a rate of 55% of the lowest trading bid price of the Companys common stock for the ten prior trading days prior to the date upon which the conversion notice was received | |||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||||
Interest and Debt Expense | 9,409 | 51,089 | 10,275 | |||||||||||||||||||||||
Debt Instrument, Periodic Payment, Principal | 45,000 | 11,755 | ||||||||||||||||||||||||
Debt Instrument, Periodic Payment, Interest | 1,887 | 553 | ||||||||||||||||||||||||
Additionally Debt Instrument Unamortized Premium | 36,818 | 61,364 | ||||||||||||||||||||||||
Convertible Notes Payable Two [Member] | Third Party [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 3,313 | |||||||||||||||||||||||||
Convertible Notes Payable Three [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 50,000 | |||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||||||||||||||||
Debt Instrument, Maturity Date | May 30, 2015 | |||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 40,909 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Terms of Conversion Feature | The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is March 20, 2016. The note is convertible at the option of the holder at any time at a rate of 55% of the lowest trading bid price of the Companys common stock for the average of the lowest three trading priced in the ten prior trading days including the date upon which the conversion notice was received. | The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is March 12, 2016. The note is convertible at the option of the holder at any time at a rate of 55% of the Companys common stock for the average of the lowest three trading prices in the ten prior trading days including the date upon which the conversion notice was received | ||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||||
Interest and Debt Expense | 9,409 | 34,273 | $ 6,636 | |||||||||||||||||||||||
Debt Instrument, Periodic Payment, Principal | 45,000 | $ 45,000 | 50,000 | |||||||||||||||||||||||
Debt Instrument, Periodic Payment, Interest | 2,229 | 3,346 | ||||||||||||||||||||||||
Additionally Debt Instrument Unamortized Premium | 36,818 | 40,909 | ||||||||||||||||||||||||
Convertible Notes Payable Four [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 43,000 | |||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||||||||||||||||
Debt Instrument, Maturity Date | Aug. 20, 2015 | |||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 31,138 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 58.00% | |||||||||||||||||||||||||
Debt Instrument, Periodic Payment, Principal | $ 15,000 | 27,851 | ||||||||||||||||||||||||
Debt Instrument, Periodic Payment, Interest | 667 | 1,527 | ||||||||||||||||||||||||
Additionally Debt Instrument Unamortized Premium | 12,273 | $ 12,273 | 36,818 | |||||||||||||||||||||||
Repayments of Debt | 61,632 | |||||||||||||||||||||||||
Debt Instrument, Annual Principal Payment | 43,000 | |||||||||||||||||||||||||
Prepayment Penalties | 17,105 | |||||||||||||||||||||||||
Debt Instrument, Increase (Decrease), Other, Net | 3,287 | |||||||||||||||||||||||||
Convertible Notes Payable Five [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 28,000 | |||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||||||||||||||||
Debt Instrument, Maturity Date | Sep. 12, 2015 | |||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 853 | |||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 20,276 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 58.00% | |||||||||||||||||||||||||
Debt Instrument, Periodic Payment, Principal | 15,657 | |||||||||||||||||||||||||
Additionally Debt Instrument Unamortized Premium | 36,818 | |||||||||||||||||||||||||
Repayments of Debt | 38,654 | |||||||||||||||||||||||||
Debt Instrument, Annual Principal Payment | 28,000 | |||||||||||||||||||||||||
Prepayment Penalties | 9,801 | |||||||||||||||||||||||||
Debt Instrument, Increase (Decrease), Other, Net | 4,619 | |||||||||||||||||||||||||
Convertible Back-End Notes Payable One [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 75,000 | |||||||||||||||||||||||||
Debt Instrument, Percentage of Repayment, If prepaid within 60 days of the issuance date | 130.00% | |||||||||||||||||||||||||
Debt Instrument, Percentage of Repayment, if prepaid 60 but less than 121 days after the issuance date | 140.00% | |||||||||||||||||||||||||
Debt Instrument, Percentage of Repayment, if prepaid 120 but less than 180 days after the issuance date | 150.00% | |||||||||||||||||||||||||
Convertible Back-End Notes Payable Two [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 75,000 | |||||||||||||||||||||||||
Convertible Back-End Notes Payable Three [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 50,000 | |||||||||||||||||||||||||
Convertible Note Payable Eight [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 104,000 | $ 104,000 | ||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | 8.00% | ||||||||||||||||||||||||
Debt Instrument, Maturity Date | Dec. 16, 2015 | |||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 2,530 | |||||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 75,310 | $ 75,310 | 46,441 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | 180 | ||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 58.00% | 58.00% | ||||||||||||||||||||||||
Interest and Debt Expense | $ 6,276 | 46,441 | ||||||||||||||||||||||||
Debt Instrument, Periodic Payment, Interest | $ 2,872 | |||||||||||||||||||||||||
Additionally Debt Instrument Unamortized Premium | 22,593 | |||||||||||||||||||||||||
Repayments of Debt | 137,915 | |||||||||||||||||||||||||
Debt Instrument, Annual Principal Payment | 104,000 | |||||||||||||||||||||||||
Prepayment Penalties | $ 31,043 | |||||||||||||||||||||||||
Convertible Note Payable Seven [Member] | ||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 58,000 | |||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||||
Debt Instrument, Maturity Date | Jul. 27, 2015 | |||||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 58,000 | 36,411 | ||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | |||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 50.00% | |||||||||||||||||||||||||
Debt Instrument, Periodic Payment, Interest | 2,212 | |||||||||||||||||||||||||
Repayments of Debt | 83,512 | |||||||||||||||||||||||||
Debt Instrument, Annual Principal Payment | 58,000 | |||||||||||||||||||||||||
Prepayment Penalties | 23,300 | |||||||||||||||||||||||||
Debt Instrument, Increase (Decrease), Other, Net | $ 21,589 |
CONVERTIBLE NOTES (Details Te37
CONVERTIBLE NOTES (Details Textual 1) | Jul. 15, 2015USD ($) | Jul. 14, 2015USD ($) | Jun. 04, 2015USD ($)$ / shares | Mar. 12, 2015USD ($)$ / shares | Jul. 02, 2014USD ($)$ / shares | Jun. 02, 2015USD ($) | May. 19, 2015USD ($) | Apr. 27, 2015USD ($) | Apr. 24, 2015USD ($) | Apr. 20, 2015USD ($) | Mar. 20, 2015USD ($) | Mar. 12, 2015USD ($)$ / shares | Feb. 20, 2015USD ($) | Feb. 17, 2015USD ($) | Feb. 15, 2015USD ($) | Feb. 10, 2015USD ($) | Jan. 27, 2015USD ($) | Jan. 26, 2015USD ($) | Jul. 18, 2014USD ($) | Sep. 30, 2015USD ($) | Sep. 30, 2014USD ($) | Jun. 30, 2015USD ($) | Jun. 30, 2014USD ($) | Mar. 19, 2015USD ($) |
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 30,000 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | $ 6,026 | |||||||||||||||||||||||
Proceeds from Notes Payable | $ 50,000 | |||||||||||||||||||||||
Noninterest Expense Transfer Agent and Custodian Fees | 7,779 | |||||||||||||||||||||||
Legal Fees | 2,500 | |||||||||||||||||||||||
Expense Related to Distribution or Servicing and Underwriting Fees | 5,000 | |||||||||||||||||||||||
Net Proceeds From Notes Issued | $ 201,997 | 34,721 | ||||||||||||||||||||||
Amortization of debt discount | 206,935 | $ 98,013 | $ 295,795 | 49,029 | ||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 50,000 | 0 | (2,500) | |||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 139,680 | 152,285 | 0 | |||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 0.07 | $ 0.0709 | ||||||||||||||||||||||
Convertible Notes Payable | $ 352,500 | $ 782,500 | $ 782,500 | |||||||||||||||||||||
Debt Convertible Note cash Purchase | 220,000 | |||||||||||||||||||||||
Proceeds from Interest Received | $ 1,997 | |||||||||||||||||||||||
Proceeds from Sale of Notes Receivable | 17,690 | |||||||||||||||||||||||
Six Month Consulting Agreement [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 5.00% | |||||||||||||||||||||||
Debt Instrument, Maturity Date | Aug. 15, 2015 | |||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 60,000 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 60.00% | |||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | $ 1,677 | $ 2,811 | ||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 90,000 | |||||||||||||||||||||||
Two Year Consulting Agreement [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | 10.00% | ||||||||||||||||||||||
Debt Instrument, Maturity Date | Mar. 11, 2017 | Mar. 11, 2017 | ||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 75.00% | 75.00% | ||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 60,000 | $ 60,000 | ||||||||||||||||||||||
Interest Payable | $ 3,337 | 1,825 | ||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 0.0175 | $ 0.0175 | ||||||||||||||||||||||
Convertible Note Payable [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | 1,215,000 | |||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 110,000 | 529,500 | 30,000 | |||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | $ 15,593 | $ 2,513 | ||||||||||||||||||||||
Debt Instrument, Percentage of Repayment, If prepaid within 60 days of the issuance date | 130.00% | 130.00% | ||||||||||||||||||||||
Debt Instrument, Percentage of Repayment, if prepaid 60 but less than 121 days after the issuance date | 140.00% | 140.00% | ||||||||||||||||||||||
Debt Instrument, Percentage of Repayment, if prepaid 120 but less than 180 days after the issuance date | 150.00% | 150.00% | ||||||||||||||||||||||
Debt Instrument, Debt Default, Interest Rate | 24.00% | |||||||||||||||||||||||
Amortization of debt discount | $ 186,935 | $ 10,171 | $ 114,033 | $ 3,133 | ||||||||||||||||||||
Percentage of Consideration Received | 10.00% | |||||||||||||||||||||||
Convertible Note Payable One [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 28,000 | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||||||||||||||
Debt Instrument, Maturity Date | Oct. 28, 2015 | |||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 20,276 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 58.00% | |||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 835 | |||||||||||||||||||||||
Debt Instrument, Periodic Payment, Principal | 15,432 | |||||||||||||||||||||||
Repayments of Debt | 37,137 | |||||||||||||||||||||||
Debt Instrument, Annual Principal Payment | 28,000 | |||||||||||||||||||||||
Prepayment Penalties | 8,302 | |||||||||||||||||||||||
Debt Instrument, Increase (Decrease), Other, Net | 4,844 | |||||||||||||||||||||||
Convertible Note Payable Two [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 7,500 | |||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 40,909 | 40,909 | ||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||
Additionally Debt Instrument Unamortized Premium | 40,909 | |||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 50,000 | |||||||||||||||||||||||
Interest Payable | 609 | |||||||||||||||||||||||
Convertible Note Payable Three [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 45,000 | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||||||||||||||
Debt Instrument, Maturity Date | Feb. 10, 2016 | |||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 7,500 | $ 7,500 | ||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 36,818 | 27,409 | ||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 1,391 | |||||||||||||||||||||||
Convertible Note Payable Four [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 170,500 | $ 170,500 | $ 45,000 | |||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||||||||||||||
Debt Instrument, Maturity Date | Feb. 17, 2016 | |||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 13,000 | 13,000 | $ 7,500 | |||||||||||||||||||||
Debt Instrument, Unamortized Premium | 139,500 | 139,500 | $ 36,818 | 27,409 | ||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 6,919 | 1,322 | ||||||||||||||||||||||
Convertible Note Payable Five [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 170,500 | $ 150,000 | $ 170,500 | |||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | 8.00% | ||||||||||||||||||||||
Debt Instrument, Maturity Date | Mar. 12, 2016 | |||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 13,000 | $ 13,000 | ||||||||||||||||||||||
Debt Instrument, Unamortized Premium | 139,500 | $ 139,500 | ||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 6,411 | 4,148 | ||||||||||||||||||||||
Convertible Note Payable Six [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 150,000 | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||||||||||||||
Debt Instrument, Maturity Date | Mar. 20, 2016 | |||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 122,727 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 3,386 | |||||||||||||||||||||||
Convertible Back-End Note Payable One [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | 45,000 | 45,000 | ||||||||||||||||||||||
Convertible Back-End Note Payable Two [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | 45,000 | 45,000 | ||||||||||||||||||||||
Convertible Back-End Note Payable Three [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | 170,500 | 170,500 | ||||||||||||||||||||||
Convertible Back-End Note Payable Four [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | 150,000 | 150,000 | ||||||||||||||||||||||
Convertible Note Payable Seven [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 58,000 | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||
Debt Instrument, Maturity Date | Jul. 27, 2015 | |||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 58,000 | 36,411 | ||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 50.00% | |||||||||||||||||||||||
Repayments of Debt | 83,512 | |||||||||||||||||||||||
Debt Instrument, Annual Principal Payment | 58,000 | |||||||||||||||||||||||
Prepayment Penalties | 23,300 | |||||||||||||||||||||||
Debt Instrument, Increase (Decrease), Other, Net | 21,589 | |||||||||||||||||||||||
Debt Instrument, Periodic Payment, Interest | 2,212 | |||||||||||||||||||||||
Convertible Note Payable Eight [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 104,000 | $ 104,000 | ||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | 8.00% | ||||||||||||||||||||||
Debt Instrument, Maturity Date | Dec. 16, 2015 | |||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 75,310 | $ 75,310 | 46,441 | |||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | 180 | ||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 58.00% | 58.00% | ||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 2,530 | |||||||||||||||||||||||
Interest and Debt Expense | 6,276 | 46,441 | ||||||||||||||||||||||
Additionally Debt Instrument Unamortized Premium | 22,593 | |||||||||||||||||||||||
Repayments of Debt | $ 137,915 | |||||||||||||||||||||||
Debt Instrument, Annual Principal Payment | 104,000 | |||||||||||||||||||||||
Prepayment Penalties | 31,043 | |||||||||||||||||||||||
Debt Instrument, Periodic Payment, Interest | $ 2,872 | |||||||||||||||||||||||
Convertible Notes Payable Ten [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 7,500 | |||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 36,818 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | $ 671 | |||||||||||||||||||||||
Interest and Debt Expense | 13,909 | 22,909 | 13,909 | |||||||||||||||||||||
Proceeds from Notes Payable | 45,000 | |||||||||||||||||||||||
Legal Fees | 2,250 | |||||||||||||||||||||||
Net Proceeds From Notes Issued | 35,250 | |||||||||||||||||||||||
Additionally Debt Instrument Unamortized Premium | 36,818 | 36,818 | ||||||||||||||||||||||
Debt Instrument, Periodic Payment, Principal | 45,000 | |||||||||||||||||||||||
Debt Instrument, Periodic Payment, Interest | 1,765 | |||||||||||||||||||||||
Convertible Notes Payable Eleven [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 104,000 | $ 104,000 | ||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 7,500 | |||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 36,818 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Trading Days | 180 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 1,578 | 671 | ||||||||||||||||||||||
Interest and Debt Expense | 32,727 | 13,909 | ||||||||||||||||||||||
Proceeds from Notes Payable | $ 45,000 | |||||||||||||||||||||||
Legal Fees | 2,250 | |||||||||||||||||||||||
Net Proceeds From Notes Issued | $ 35,250 | |||||||||||||||||||||||
Convertible Notes Payable Twelve [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 13,000 | |||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 139,500 | 147,409 | ||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 5,867 | 2,429 | ||||||||||||||||||||||
Proceeds from Notes Payable | $ 170,500 | |||||||||||||||||||||||
Legal Fees | 7,500 | |||||||||||||||||||||||
Net Proceeds From Notes Issued | 334,810 | $ 150,000 | ||||||||||||||||||||||
Additionally Debt Instrument Unamortized Premium | $ 288,409 | |||||||||||||||||||||||
Convertible Promissory Back-End Notes One [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Convertible Notes Payable | 37,500 | |||||||||||||||||||||||
Convertible Promissory Back-End Notes Two [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Convertible Notes Payable | 37,500 | |||||||||||||||||||||||
Convertible Promissory Back-End Notes Three [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Convertible Notes Payable | 157,500 | |||||||||||||||||||||||
Convertible Promissory Back-End Notes Four [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Convertible Notes Payable | 150,000 | |||||||||||||||||||||||
Convertible Promissory Back-End Notes Five [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Convertible Notes Payable | 17,500 | |||||||||||||||||||||||
Convertible Promissory Back-End Notes Six [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Convertible Notes Payable | 37,500 | |||||||||||||||||||||||
Convertible Promissory Back-End Notes Seven [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Convertible Notes Payable | 37,500 | |||||||||||||||||||||||
Convertible Promissory Back-End Notes Eight [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Convertible Notes Payable | 157,500 | |||||||||||||||||||||||
Convertible Promissory Back-End Notes Nine [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Convertible Notes Payable | $ 150,000 | |||||||||||||||||||||||
Convertible Notes Payable Fourteen [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 122,727 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 5,162 | 2,137 | ||||||||||||||||||||||
Proceeds from Notes Payable | $ 150,000 | |||||||||||||||||||||||
Legal Fees | 7,500 | |||||||||||||||||||||||
Net Proceeds From Notes Issued | $ 142,500 | |||||||||||||||||||||||
Secured Investor Note One [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 30,000 | |||||||||||||||||||||||
Legal Fees | 5,000 | |||||||||||||||||||||||
Debt Convertible Note cash Purchase | 335,000 | |||||||||||||||||||||||
Secured Investor Note Two [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 20,000 | |||||||||||||||||||||||
Debt Convertible Note cash Purchase | 220,000 | |||||||||||||||||||||||
Secured Investor Note Three [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 20,000 | |||||||||||||||||||||||
Debt Convertible Note cash Purchase | $ 220,000 | |||||||||||||||||||||||
Execution Note [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 30,000 | |||||||||||||||||||||||
Legal Fees | $ 5,000 | |||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 0.07 | |||||||||||||||||||||||
Debt Convertible Note cash Purchase | $ 300,000 | |||||||||||||||||||||||
Secured Debt, Secured Percentage by Lender | 40.00% | |||||||||||||||||||||||
Market Capitalization Minimum Amount | $ 3,000,000 | |||||||||||||||||||||||
Convertible Note Payable Nine [Member] | ||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 17,500 | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||||||||||||||
Debt Instrument, Maturity Date | Apr. 20, 2016 | |||||||||||||||||||||||
Debt Instrument, Unamortized Premium | $ 14,318 | |||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | $ 625 | $ 272 |
LOANS AND NOTES PAYABLE (Detail
LOANS AND NOTES PAYABLE (Details Textual) - USD ($) | Feb. 04, 2015 | Jul. 02, 2014 | Jan. 30, 2015 | Nov. 04, 2014 | Sep. 11, 2014 | Jul. 18, 2014 | May. 31, 2014 | Sep. 30, 2013 | Sep. 30, 2015 | Sep. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 04, 2015 | Jul. 31, 2014 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 139,680 | $ 152,285 | $ 0 | ||||||||||||
Decrease In Liability Due To Director | 44,000 | ||||||||||||||
Notes Payable, Current | $ 6,278 | 27,558 | 33,909 | ||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 2,183,333 | ||||||||||||||
Debt Conversion, Original Debt, Amount | $ 50,000 | 0 | $ (2,500) | ||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.0709 | $ 0.07 | |||||||||||||
Increase In The Liability Part Of Settlement Agreement | $ 44,000 | ||||||||||||||
Conversion of Stock, Amount Converted | 122,727 | 0 | 71,370 | 0 | |||||||||||
Other Liabilities | 575,000 | ||||||||||||||
Gains (Losses) on Extinguishment of Debt, Total | 0 | (36,263) | 375,547 | 0 | |||||||||||
Other Long-term Debt, Current | 33,909 | ||||||||||||||
Payments for Loans | 13,549 | $ 8,725 | $ 28,455 | 45,512 | |||||||||||
Loans from Directors [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 27,000 | ||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 33,259,350 | ||||||||||||||
Settlement And Lock Up Agreement [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Other Liabilities | 575,000 | ||||||||||||||
Settlement And Lock Up Agreement [Member] | Loans from Directors [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Increase In The Liability Part Of Settlement Agreement | 109,000 | ||||||||||||||
Settlement Agreement [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | 8,161,000 | 7,426,000 | |||||||||||||
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | $ 81,396 | ||||||||||||||
Promissory Note [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Debt Conversion, Converted Instrument, Amount | 50,000 | ||||||||||||||
Debt Conversion, Original Debt, Amount | $ 25,000 | ||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.0025 | ||||||||||||||
Gain Or Loss On Debt Conversion Original Debt | $ 51,466 | ||||||||||||||
Conversion of Stock, Amount Converted | 25,000 | 25,000 | |||||||||||||
Gains (Losses) on Extinguishment of Debt, Total | 51,466 | ||||||||||||||
Interest Payable | $ 1,466 | ||||||||||||||
Promissory Note [Member] | Settlement And Lock Up Agreement [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 10,000,000 | ||||||||||||||
Debt Conversion, Original Debt, Amount | $ 50,000 | ||||||||||||||
Promissory Note [Member] | Settlement Agreement [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Interest Payable | $ 1,466 | ||||||||||||||
Lender [Member] | Settlement Agreement [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Debt Instrument, Unamortized Premium | 17,000 | ||||||||||||||
Debt Instrument, Face Amount | 50,000 | ||||||||||||||
Gains (Losses) on Extinguishment of Debt, Total | $ 310,000 | ||||||||||||||
Non-Interest Bearing [Member] | Investor [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Debt Instrument, Fee Amount | 50,000 | ||||||||||||||
Non-Interest Bearing [Member] | Promissory Note [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Debt Instrument, Fee Amount | $ 50,000 | ||||||||||||||
Two unrelated parties [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Long-term Debt, Gross | $ 33,614 | ||||||||||||||
Debt Instrument, Interest Rate During Period | 10.00% | ||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 27,963 | ||||||||||||||
unrelated parties [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Long-term Debt, Gross | $ 9,419 | ||||||||||||||
Debt Instrument, Interest Rate During Period | 10.00% | ||||||||||||||
Notes Payable, Current | 27,558 | ||||||||||||||
unrelated parties [Member] | Settlement Agreement [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Notes Payable, Current | $ 33,909 | ||||||||||||||
unrelated parties [Member] | Lender [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Debt Instrument, Fee Amount | $ 50,000 | ||||||||||||||
Notes Payable, Current | 1,033,000 | ||||||||||||||
Debt Instrument, Unamortized Premium | 355,000 | ||||||||||||||
Debt Instrument, Face Amount | $ 628,000 | ||||||||||||||
unrelated parties [Member] | Non-Interest Bearing [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Long-term Debt, Gross | 18,839 | ||||||||||||||
Directors and Officer [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Long-term Debt, Gross | $ 59,360 | 79,416 | $ 161,975 | ||||||||||||
Director [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 14,000 | ||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 17,654,470 | ||||||||||||||
Director [Member] | Loans from Directors [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 41,000 | ||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.0025 | ||||||||||||||
Gain Or Loss On Debt Conversion Original Debt | $ 86,455 | ||||||||||||||
Conversion of Stock, Amount Converted | 127,284 | ||||||||||||||
Gains (Losses) on Extinguishment of Debt, Total | $ 86,455 | ||||||||||||||
Director [Member] | Settlement Agreement [Member] | |||||||||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||||||||||||
Decrease In Liability Due To Director | $ 127,000 |
STOCKHOLDERS' DEFICIT (Details)
STOCKHOLDERS' DEFICIT (Details) - Warrant [Member] - USD ($) | 12 Months Ended | |
Jun. 30, 2015 | Jun. 30, 2014 | |
Number of Shares Outstanding-Beginning Balance (In shares) | 3,000,000 | 0 |
Number of Shares-Issued | 4,379,158 | 3,000,000 |
Number of Shares-Exercised | 0 | 0 |
Number of Shares-Expired | 0 | 0 |
Number of Shares Outstanding-Ending Balance (In shares) | 7,379,158 | 3,000,000 |
Number of Shares Exercisable | 7,379,158 | |
Outstanding and Exercisable: | ||
Number of Shares-Weighted average remaining contractual term | 4 years 2 months 16 days | |
Number of Shares-Aggregate intrinsic value | $ 319,774 | |
Weighted Average Price pre share-Beginning Balance | $ 0.07 | $ 0 |
Weighted Average Price pre share-Issued | 0.04 | 0.07 |
Weighted Average Price pre share-Exercised | 0 | 0 |
Weighted Average Price pre share-Expired | 0 | 0 |
Weighted Average Price pre share-Ending Balance | 0.05 | $ 0.07 |
Weighted Average Price Per Shares Exercisable | $ 0.05 |
STOCKHOLDERS' DEFICIT (Details
STOCKHOLDERS' DEFICIT (Details Textual) - USD ($) | Sep. 16, 2015 | Sep. 08, 2015 | Sep. 04, 2015 | Sep. 02, 2015 | Aug. 14, 2015 | Jul. 02, 2015 | Jun. 16, 2015 | Jun. 05, 2015 | Jun. 04, 2015 | Jun. 03, 2015 | May. 07, 2015 | Apr. 14, 2015 | Mar. 17, 2015 | Mar. 16, 2015 | Mar. 12, 2015 | Mar. 11, 2015 | Mar. 06, 2015 | Feb. 17, 2015 | Feb. 09, 2015 | Feb. 04, 2015 | Feb. 02, 2015 | Dec. 10, 2014 | Dec. 09, 2014 | Dec. 04, 2014 | Nov. 04, 2014 | Aug. 07, 2014 | Jul. 02, 2014 | May. 09, 2014 | Sep. 22, 2015 | Sep. 18, 2015 | Aug. 26, 2015 | Jul. 24, 2015 | May. 21, 2015 | Apr. 28, 2015 | Apr. 21, 2015 | Apr. 15, 2015 | Mar. 20, 2015 | Mar. 19, 2015 | Mar. 18, 2015 | Jan. 30, 2015 | Dec. 26, 2014 | Dec. 24, 2014 | Dec. 16, 2014 | Dec. 11, 2014 | Nov. 05, 2014 | Oct. 17, 2014 | Sep. 11, 2014 | Jul. 18, 2014 | Nov. 30, 2013 | Oct. 31, 2013 | Sep. 30, 2013 | Jul. 31, 2013 | Sep. 30, 2015 | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2013 | Jul. 10, 2015 | Feb. 28, 2015 | Nov. 12, 2014 | Oct. 31, 2014 |
Debt Instrument, Convertible, Conversion Price | $ 0.07 | $ 0.0709 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 139,680 | $ 152,285 | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Periodic Payment | $ 154,798 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants Expire Period | 5 years | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | $ 3,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.0698 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 2,183,333 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 3,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 741,276 | $ 244,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock, authorized shares | 2,000,000,000 | 2,000,000,000 | 2,000,000,000 | 10,000,000,000 | 100,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 50,000 | $ 0 | $ (2,500) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Outstanding | 7,379,158 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share Price | $ 0.0289 | 0.0899 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Scientific Advisory Board [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.0369 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.0025 | $ 0.0025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 25,000 | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 10,000,000 | 10,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 19,258,316 | 1,915,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.0025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 19,258 | $ 1,915 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock, authorized shares | 2,000,000,000 | 10,000,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock, par value | $ 0.001 | $ 0.001 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | 181,185,110 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock [Member] | Investment Banking Service Agreement [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, authorized shares | 10,000,000 | 10,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, par value | $ 0.01 | $ 0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Director [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 14,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 17,654,470 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investor [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 1,000,000 | 9,400,000 | 1,000,000 | 3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.0025 | $ 0.0025 | $ 0.001 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 23,500 | $ 2,500 | $ 3,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
First Tranche [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues | 7,426,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Second Tranche [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues | 8,161,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Settlement Agreements [Member] | Director [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 44,136 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 17,654,470 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 500,000 | 4,000,000 | 500,000 | 560,000 | 8,000,000 | 500,000 | 6,000,000 | 10,000,000 | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.10 | $ 0.04 | $ 0.0435 | $ 0.008 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 100,000 | $ 4,261 | $ 348,000 | $ 80,000 | $ 17,746 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 8,000,000 | 3,000,000 | 3,000,000 | 4,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 500,000 | 6,758,316 | 500,000 | 1,000,000 | 6,758,316 | 1,000,000 | 300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.0706 | $ 0.043 | $ 0.0445 | $ 0.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 5,015 | $ 88,446 | $ 35,300 | $ 7,265 | $ 290,608 | $ 44,500 | $ 12,000 | $ 48,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 3,379,158 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share Price | $ 0.043 | $ 0.0445 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant [Member] | Warrant [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price | $ 0.03 | $ 0.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 397.00% | 397.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term | 60 months | 60 months | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | 1.54% | 1.54% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 145,303 | $ 44,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prepaid Expense | 101,080 | 37,235 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation, Total | $ 44,223 | $ 7,265 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant One [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 80,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | 281,313 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant One [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 250,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant Two [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, New Issues | $ 128,609 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant Two [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 137,500 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 27,500 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant Three [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 10,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 2,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant Four [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 150,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 30,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant Six [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 60,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant Seven [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 25,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 5,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant Eight [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 13,333 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Increase (Decrease) in Prepaid Expense | $ 6,667 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant Nine [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 10,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant Ten [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 30,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 3,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consultant Eleven [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 25,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 2,500 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issue One [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.02365 | $ 0.0020 | $ 0.0017 | $ 0.0017 | $ 0.0015 | $ 0.0015 | $ 0.0006 | $ 0.0006 | $ 0.0035 | $ 0.0006 | $ 0.0011 | $ 0.0011 | $ 0.0020 | $ 0.0020 | $ 0.0020 | $ 0.0020 | $ 0.0020 | $ 0.0007 | $ 0.0007 | $ 0.0012 | ||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Periodic Payment | $ 4,271 | $ 1,061 | $ 15,534 | $ 1,001 | $ 14,675 | $ 3,410 | $ 3,266 | $ 21,100 | $ 3,446 | $ 28,202 | $ 10,145 | $ 23,762 | $ 8,260 | $ 20,053 | $ 4,044 | $ 3,762 | $ 6,000 | |||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 866,796 | 6,698,331 | 4,870,391 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 20,500 | $ 7,368 | $ 5,357 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | 2,135,450 | 622,504 | 9,110,833 | 674,141 | 9,882,013 | 6,200,000 | 5,937,563 | 6,089,544 | 6,265,964 | 14,100,870 | 5,072,740 | 12,001,242 | 4,171,808 | 10,127,576 | 5,655,958 | 5,700,000 | 5,194,805 | |||||||||||||||||||||||||||||||||||||||||||||
Issue Two [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.02365 | $ 0.0019 | $ 0.0015 | $ 0.0015 | $ 0.0015 | $ 0.0035 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Periodic Payment | $ 20,048 | $ 14,678 | $ 10,121 | $ 6,443 | $ 15,323 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 879,585 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 20,802 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | 10,414,660 | 9,884,155 | 6,815,185 | 4,338,384 | 4,422,257 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issue Three [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.0016 | $ 0.0015 | $ 0.018425 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Periodic Payment | $ 10,125 | $ 1,011 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 1,414,843 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 26,068 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | 6,347,918 | 680,485 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issue Four [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.018425 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 1,396,108 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 25,723 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issue Five [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.018425 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 849,263 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 15,648 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issue Six [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.018975 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 826,726 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 15,687 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issue Seven [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.017875 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 877,969 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 15,694 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issue Eight [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.01716 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 911,294 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 15,638 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loans from Directors [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 27,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 33,259,350 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loans from Directors [Member] | Director [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.0025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 41,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loans from Directors [Member] | Debt Settlement Agreements [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 83,148 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 33,259,350 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series A Preferred Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues | 8,161,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, authorized shares | 500,000 | 10,000,000 | 10,000,000 | 10,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, par value | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 500,000 | 500,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.00213 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 1,067 | $ 5,000 | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series B Preferred Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, authorized shares | 5 | 5 | 5 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, par value | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 1 | 1 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.1165 | $ 0.1165 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 0.12 | $ 0 | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | 0 |
COMMITMENTS AND CONTINGIENCIES
COMMITMENTS AND CONTINGIENCIES (Details Textual) - USD ($) | Jul. 02, 2014 | May. 31, 2015 | Jan. 30, 2015 | Jul. 31, 2014 | Jul. 18, 2014 | May. 31, 2014 | Nov. 30, 2009 | Sep. 30, 2015 | Sep. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | Jun. 04, 2015 | Apr. 30, 2015 | Jul. 31, 2013 |
Commitments And Contingencies [Line Items] | ||||||||||||||
Operating Leases, Rent Expense | $ 4,938 | $ 2,777 | $ 3,719 | $ 11,016 | ||||||||||
Accrued Rent | $ 1,000 | |||||||||||||
Sale of Stock, Number of Shares Issued in Transaction | 15,587,000 | |||||||||||||
Sale Of Stock Decreased liability Owed To Purchaser | $ 52,907 | |||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.0709 | $ 0.07 | ||||||||||||
Payments for Fees | $ 50,000 | |||||||||||||
Debt Conversion, Original Debt, Amount | $ 50,000 | 0 | (2,500) | |||||||||||
Interest Expense, Debt | 405,000 | |||||||||||||
Long-term Purchase Commitment, Period | 24 months | |||||||||||||
Other Liabilities | $ 575,000 | |||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 2,183,333 | |||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 139,680 | 152,285 | 0 | |||||||||||
Conversion of Stock, Amount Converted | 122,727 | 0 | 71,370 | 0 | ||||||||||
Gains (Losses) on Extinguishment of Debt, Total | 0 | $ (36,263) | $ 375,547 | $ 0 | ||||||||||
Common Stock [Member] | ||||||||||||||
Commitments And Contingencies [Line Items] | ||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.0025 | $ 0.0025 | ||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 10,000,000 | 10,000,000 | ||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 25,000 | $ 25,000 | ||||||||||||
Promissory Note [Member] | ||||||||||||||
Commitments And Contingencies [Line Items] | ||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.0025 | |||||||||||||
Debt Conversion, Original Debt, Amount | $ 25,000 | |||||||||||||
Debt Conversion, Converted Instrument, Amount | 50,000 | |||||||||||||
Interest Payable | 1,466 | |||||||||||||
Conversion of Stock, Amount Converted | 25,000 | $ 25,000 | ||||||||||||
Gains (Losses) on Extinguishment of Debt, Total | 51,466 | |||||||||||||
Loss Contingency, Estimate of Possible Loss | $ 25,000 | |||||||||||||
Settlement Agreement [Member] | Promissory Note [Member] | ||||||||||||||
Commitments And Contingencies [Line Items] | ||||||||||||||
Interest Payable | 1,466 | |||||||||||||
Equity Purchase Agreement [Member] | Investor [Member] | ||||||||||||||
Commitments And Contingencies [Line Items] | ||||||||||||||
Percentage Of Common Stock Outstanding | 9.99% | |||||||||||||
Percentage Of Market Price Of Common Stock | 90.00% | |||||||||||||
Long-term Purchase Commitment, Amount | $ 5,000,000 | |||||||||||||
Purchaser [Member] | ||||||||||||||
Commitments And Contingencies [Line Items] | ||||||||||||||
Debt Instrument, Unamortized Premium | 310,000 | |||||||||||||
Debt Instrument, Fee Amount | $ 67,000 | |||||||||||||
Purchaser [Member] | Share-based Compensation Award, Tranche One [Member] | ||||||||||||||
Commitments And Contingencies [Line Items] | ||||||||||||||
Stock Issued During Period, Shares, New Issues | 15,587,000 | |||||||||||||
Purchaser [Member] | Settlement Agreement [Member] | ||||||||||||||
Commitments And Contingencies [Line Items] | ||||||||||||||
Payments for Fees | $ 25,000 | |||||||||||||
Percentage Of Net Proceeds From Issuance Of Common Stock | 65.00% | |||||||||||||
Percentage Of Common Stock Outstanding | 9.99% | |||||||||||||
Loss Contingency, Damages Sought, Value | $ 627,998 | |||||||||||||
Obligated to Issue Common Stock to Purchaser | $ 50,000 | |||||||||||||
Percentage of Average Closing Bid Prices | 75.00% | |||||||||||||
Purchaser [Member] | Equity Purchase Agreement [Member] | ||||||||||||||
Commitments And Contingencies [Line Items] | ||||||||||||||
Obligated to Issue Common Stock to Purchaser | $ 1,033,000 | |||||||||||||
Lease Agreements [Member] | ||||||||||||||
Commitments And Contingencies [Line Items] | ||||||||||||||
Payments for Fees | $ 2,200 | |||||||||||||
Royalty Agreement Terms [Member] | ||||||||||||||
Commitments And Contingencies [Line Items] | ||||||||||||||
Operating Leases Income Statement Revenue Percentage | 2.00% | |||||||||||||
License Agreement Terms [Member] | ||||||||||||||
Commitments And Contingencies [Line Items] | ||||||||||||||
Accrued Rent | $ 21,000 | |||||||||||||
Operating Leases Income Statement Revenue Percentage | 5.00% |
INCOME TAXES (Details)
INCOME TAXES (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2015 | Sep. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Current Taxes | $ (77,470) | $ (48,267) | ||
Deferred Taxes | 0 | 0 | ||
Income Taxes Expense (Benefit) | $ 0 | $ 0 | $ (77,470) | $ (48,267) |
INCOME TAXES (Details 1)
INCOME TAXES (Details 1) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2015 | Sep. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Income Tax Expense (Benefit) at Australia Statutory Rate | $ (672,087) | $ (274,229) | ||
Expenses Paid by Parent on Behalf of Foreign Subsidiary | 156,410 | 92,480 | ||
R&D Refundable Tax Credit | (77,470) | (48,267) | ||
Reduction of NOL Carryforward Due to R&D Tax Credit | 77,470 | 48,267 | ||
Change in Deferred Tax Valuation Allowance | (355,636) | 260,533 | ||
Foreign Exchange Rate Changes | 793,843 | (127,051) | ||
Total Income Tax Expense (Benefit) | $ 0 | $ 0 | $ (77,470) | $ (48,267) |
Income Tax Expense (Benefit) at Australia Statutory Rate, Impact on Rate | (19.26%) | (31.24%) | ||
Expenses paid by parent on behalf of foreign subsidiary, Impact on Rate | 4.48% | 10.54% | ||
R&D Refundable Tax Credit, Impact on Rate, Impact on Rate | (2.22%) | (5.50%) | ||
Reduction of NOL Carryforward Due to R&D Tax Credit, Impact on Rate | 2.22% | 5.50% | ||
Change in deferred Tax Valuation Allowance, Impact on Rate | (10.19%) | 29.68% | ||
Foreign Exchange Rate Changes, Impact on Rate | 22.74% | (14.47%) | ||
Total Income Tax Expense (Benefit), Impact on Rate | (2.22%) | (5.50%) |
INCOME TAXES (Details 2)
INCOME TAXES (Details 2) - USD ($) | Jun. 30, 2015 | Jun. 30, 2014 |
Current Deferred Tax Assets | ||
Total Current Deferred Tax Assets | $ 109,630 | $ 50,872 |
Current Deferred Tax Liabilities | ||
Total Current Deferred Tax Liabilities | 0 | 0 |
Non-Current Deferred Tax Assets | ||
Total Non-Current Deferred Tax Assets | 3,706,452 | 4,241,995 |
Deferred Tax Valuation Allowance | (3,816,082) | (4,292,867) |
Total Non-Current Deferred Tax Assets | (109,630) | (50,872) |
Total Deferred Tax Assets (Net) | 0 | 0 |
Warrant Derivative Liability [Member] | ||
Current Deferred Tax Assets | ||
Total Current Deferred Tax Assets | 88,204 | 28,209 |
Provision For Annual Leave [Member] | ||
Current Deferred Tax Assets | ||
Total Current Deferred Tax Assets | 21,426 | 18,848 |
Superannuation [Member] | ||
Current Deferred Tax Assets | ||
Total Current Deferred Tax Assets | 0 | 3,815 |
Prepaid Investor Services [Member] | ||
Current Deferred Tax Liabilities | ||
Total Current Deferred Tax Liabilities | 0 | 0 |
Non-Current Deferred Tax Assets | ||
Total Non-Current Deferred Tax Assets | 185,025 | 751,917 |
Prepaid Expenses [Member] | ||
Current Deferred Tax Liabilities | ||
Total Current Deferred Tax Liabilities | 0 | 0 |
Prepaid Insurance [Member] | ||
Current Deferred Tax Liabilities | ||
Total Current Deferred Tax Liabilities | 0 | 0 |
Accounts Payable/Trade Creditors [Member] | ||
Current Deferred Tax Liabilities | ||
Total Current Deferred Tax Liabilities | 0 | 0 |
Patent Costs [Member] | ||
Current Deferred Tax Liabilities | ||
Total Current Deferred Tax Liabilities | 0 | 0 |
Non-Current Deferred Tax Assets | ||
Total Non-Current Deferred Tax Assets | 59,995 | 59,473 |
Capital Raising Costs [Member] | ||
Non-Current Deferred Tax Assets | ||
Total Non-Current Deferred Tax Assets | 23,261 | 28,622 |
Legal Costs [Member] | ||
Non-Current Deferred Tax Assets | ||
Total Non-Current Deferred Tax Assets | 23,583 | 29,019 |
Intellectual Property [Member] | ||
Non-Current Deferred Tax Assets | ||
Total Non-Current Deferred Tax Assets | 11,612 | 14,288 |
Formation Expense [Member] | ||
Non-Current Deferred Tax Assets | ||
Total Non-Current Deferred Tax Assets | 7,117 | 8,757 |
Net Operating Loss Carryover [Member] | ||
Non-Current Deferred Tax Assets | ||
Total Non-Current Deferred Tax Assets | 3,426,149 | 3,259,060 |
Foreign Exchange Loss (OCI) [Member] | ||
Non-Current Deferred Tax Assets | ||
Total Non-Current Deferred Tax Assets | $ (30,290) | $ 90,859 |
INCOME TAXES (Details Textual)
INCOME TAXES (Details Textual) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2015 | Sep. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Operating Income (Loss) | $ (1,007,391) | $ (238,138) | $ (1,705,587) | $ (761,221) |
Research Tax Credit Carryforward [Member] | ||||
Tax Credit Carryforward, Amount | 1,527,228 | |||
Australian Taxation Office [Member] | ||||
Operating Income (Loss) | $ 12,486,000 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details Textual) - USD ($) | Feb. 04, 2015 | Jul. 02, 2014 | Sep. 30, 2015 | Sep. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | Jun. 04, 2015 |
Related Party Transaction [Line Items] | |||||||
Due to Related Parties, Current | $ 31,994 | $ 35,108 | $ 60,350 | ||||
Loans From Related Party | 59,360 | 79,416 | 161,975 | ||||
Debt Conversion, Converted Instrument, Shares Issued | 2,183,333 | ||||||
Debt Conversion, Converted Instrument, Amount | $ 139,680 | 152,285 | 0 | ||||
Debt Instrument, Convertible, Conversion Price | $ 0.0709 | $ 0.07 | |||||
Conversion of Stock, Amount Converted | 122,727 | $ 0 | 71,370 | 0 | |||
Gains (Losses) on Extinguishment of Debt, Total | 0 | $ (36,263) | 375,547 | 0 | |||
Loans from Directors [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Debt Conversion, Converted Instrument, Shares Issued | 33,259,350 | ||||||
Debt Conversion, Converted Instrument, Amount | $ 27,000 | ||||||
Director [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Loans From Related Party | 59,360 | 79,416 | 161,975 | ||||
Debt Conversion, Converted Instrument, Shares Issued | 17,654,470 | ||||||
Debt Conversion, Converted Instrument, Amount | $ 14,000 | ||||||
Director [Member] | Loans from Directors [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Debt Conversion, Converted Instrument, Amount | $ 41,000 | ||||||
Debt Instrument, Convertible, Conversion Price | $ 0.0025 | ||||||
Conversion of Stock, Amount Converted | $ 127,284 | ||||||
Gains (Losses) on Extinguishment of Debt, Total | $ 86,455 | ||||||
Two Directors [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Due to Related Parties, Current | $ 31,994 | $ 35,108 | $ 60,350 |
CONCENTRATIONS AND RISKS (Detai
CONCENTRATIONS AND RISKS (Details Textual) | 3 Months Ended | 12 Months Ended | |
Sep. 30, 2015 | Jun. 30, 2015 | Jun. 30, 2014 | |
Reimbursement On Goods And Service Tax Receivable Percentage | 100.00% | 100.00% | 100.00% |
DERIVATIVE FINANCIAL INSTRUME48
DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Details) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2015 | Sep. 30, 2013 | Jun. 30, 2015 | Jun. 30, 2014 | |
Convertible Debt [Member] | ||||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||||
Volatility | 414.00% | 408.00% | ||
Risk-free interest rate | 0.60% | 0.64% | ||
Expected dividend yield | 0.00% | |||
Convertible Debt [Member] | Maximum [Member] | ||||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||||
Volatility | 377.00% | |||
Expected remaining term | 1 year 5 months 12 days | 1 year 8 months 12 days | 2 years | |
Risk-free interest rate | 0.70% | |||
Convertible Debt [Member] | Minimum [Member] | ||||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||||
Volatility | 216.00% | |||
Expected remaining term | 6 months 4 days | 9 months 25 days | 9 months 29 days | |
Risk-free interest rate | 0.50% | |||
Warrants [Member] | ||||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||||
Volatility | 216.00% | 53.00% | 408.00% | 134.00% |
Expected remaining term | 3 years | 5 years | 3 years 3 months | 4 years 3 months |
Risk-free interest rate | 1.37% | 0.40% | 1.63% | 0.47% |
Expected dividend yield | 0.00% | |||
Initial Valuations On Derivative [Member] | Convertible Debt [Member] | ||||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||||
Volatility | 408.00% | |||
Expected remaining term | 9 months 29 days | |||
Risk-free interest rate | 0.70% | |||
Expected dividend yield | 0.00% |
DERIVATIVE FINANCIAL INSTRUME49
DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Details 1) - USD ($) | Sep. 30, 2015 | Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2013 |
Derivative [Line Items] | ||||
Embedded conversion option liabilities | $ 350,063 | $ 780,281 | ||
Fair value of liability for warrant derivative instruments | 86,662 | 269,648 | $ 158,244 | |
Total | 436,725 | 1,049,929 | 158,244 | $ 0 |
Fair Value, Inputs, Level 1 [Member] | ||||
Derivative [Line Items] | ||||
Embedded conversion option liabilities | 0 | 0 | ||
Fair value of liability for warrant derivative instruments | 0 | 0 | 0 | |
Total | 0 | 0 | ||
Fair Value, Inputs, Level 2 [Member] | ||||
Derivative [Line Items] | ||||
Embedded conversion option liabilities | 0 | 0 | ||
Fair value of liability for warrant derivative instruments | 0 | 0 | 0 | |
Total | 0 | 0 | ||
Fair Value, Inputs, Level 3 [Member] | ||||
Derivative [Line Items] | ||||
Embedded conversion option liabilities | 350,063 | 780,281 | ||
Fair value of liability for warrant derivative instruments | 86,662 | 269,648 | $ 158,244 | |
Total | $ 436,725 | $ 1,049,929 |
DERIVATIVE FINANCIAL INSTRUME50
DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Details 2) - USD ($) | 3 Months Ended | 12 Months Ended | |
Sep. 30, 2015 | Jun. 30, 2015 | Jun. 30, 2014 | |
Balance at Beginning | $ 1,049,929 | $ 158,244 | $ 0 |
Effects of foreign currency exchange rate changes | (17,351) | (42,796) | (2,519) |
Initial fair value of embedded conversion option derivative liability recorded as debt discount | 200,000 | 392,500 | 144,241 |
Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO | 4,610 | 1,082,567 | |
Change in fair value included in statements of operations | (800,463) | (540,586) | 16,522 |
Balance at Ending | $ 436,725 | $ 1,049,929 | $ 158,244 |
DERIVATIVE FINANCIAL INSTRUME51
DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Details Textual) - USD ($) | Sep. 30, 2015 | Jun. 30, 2015 |
Derivative Instruments And Hedging Activities [Line Items] | ||
Class of Warrant or Right, Outstanding | 7,379,158 | |
Share Price | $ 0.0289 | $ 0.0899 |
Repricing option [Member] | ||
Derivative Instruments And Hedging Activities [Line Items] | ||
Convertible Debt | $ 555,000 | $ 335,000 |
Variable conversion pricing [Member] | ||
Derivative Instruments And Hedging Activities [Line Items] | ||
Class of Warrant or Right, Outstanding | 3,000,000 | 3,000,000 |
Convertible Debt | $ 87,500 | $ 87,500 |
SUBSEQUENT EVENTS (Details Text
SUBSEQUENT EVENTS (Details Textual) - USD ($) | Apr. 01, 2016 | Oct. 16, 2015 | Oct. 15, 2015 | Oct. 13, 2015 | Oct. 08, 2015 | Oct. 07, 2015 | Oct. 01, 2015 | Sep. 16, 2015 | Sep. 08, 2015 | Sep. 04, 2015 | Aug. 14, 2015 | Jul. 15, 2015 | Jul. 14, 2015 | Dec. 04, 2014 | Jul. 02, 2014 | Oct. 28, 2015 | Sep. 24, 2015 | Sep. 22, 2015 | Sep. 18, 2015 | Sep. 01, 2015 | Aug. 26, 2015 | May. 19, 2015 | Jan. 27, 2015 | Jul. 18, 2014 | Sep. 30, 2015 | Sep. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | Jul. 10, 2015 | Jun. 04, 2015 | Nov. 12, 2014 | Sep. 30, 2013 |
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Proceeds from Notes Payable | $ 50,000 | |||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 2,183,333 | |||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 50,000 | $ 0 | $ (2,500) | |||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.0709 | $ 0.07 | ||||||||||||||||||||||||||||||
Legal Fees | $ 2,500 | |||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 30,000 | |||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 3,000,000 | |||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 6,026 | |||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 55.00% | |||||||||||||||||||||||||||||||
Promissory Note Payable Issued For Services | $ 0 | $ 50,000 | ||||||||||||||||||||||||||||||
Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.0698 | |||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 139,680 | $ 152,285 | $ 0 | |||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | 741,276 | 244,500 | ||||||||||||||||||||||||||||||
Secured Investor Note [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 20,000 | |||||||||||||||||||||||||||||||
Secured Debt | 220,000 | |||||||||||||||||||||||||||||||
Proceeds from Issuance of Secured Debt | 201,997 | |||||||||||||||||||||||||||||||
Interest Proceeds Received | $ 1,997 | |||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.07 | |||||||||||||||||||||||||||||||
Promissory Note [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 448,532 | $ 415,467 | $ 121,059 | |||||||||||||||||||||||||||||
Subsequent Event [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Repayments of Debt | $ 137,915 | |||||||||||||||||||||||||||||||
Debt Instrument, Annual Principal Payment | 104,000 | |||||||||||||||||||||||||||||||
Debt Instrument, Periodic Payment, Interest | 2,872 | |||||||||||||||||||||||||||||||
Debt Instrument Prepayment Penalty | $ 31,043 | |||||||||||||||||||||||||||||||
Discount On Debt Issued Percentage | 30.00% | |||||||||||||||||||||||||||||||
Subsequent Event [Member] | Three Notes Issued [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Proceeds from Notes Payable | $ 352,500 | |||||||||||||||||||||||||||||||
Legal Fees | 17,690 | |||||||||||||||||||||||||||||||
Net Proceeds From Notes Payable | $ 334,810 | |||||||||||||||||||||||||||||||
Subsequent Event [Member] | Conversion Notice [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 5,000,000 | 8,808,435 | 2,535,293 | 2,152,289 | 826,726 | 866,796 | 911,294 | 877,969 | 1,396,108 | 1,414,843 | ||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 15,687 | $ 20,500 | $ 15,638 | $ 15,694 | $ 25,723 | $ 26,068 | ||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.01 | $ 0.012375 | $ 0.012375 | $ 0.012375 | $ 0.018975 | $ 0.02365 | $ 0.01716 | $ 0.017875 | $ 0.018425 | $ 0.018425 | ||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 50,000 | $ 109,004 | $ 31,374 | $ 26,635 | ||||||||||||||||||||||||||||
Subsequent Event [Member] | Conversion Notice One [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 8,461,602 | 849,263 | 879,585 | |||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 15,648 | $ 20,802 | ||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.012375 | $ 0.018425 | $ 0.02365 | |||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 104,712 | |||||||||||||||||||||||||||||||
Subsequent Event [Member] | Securities Purchase Agreement [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 4,400,000 | |||||||||||||||||||||||||||||||
Warrant Issued To Purchase Of Shares | 26,190,476 | |||||||||||||||||||||||||||||||
Cancellation Of Debt | $ 1,200,000 | |||||||||||||||||||||||||||||||
Amount Will Be Deposited Into Deposit Contro Account | 2,800,000 | |||||||||||||||||||||||||||||||
Debt Instrument Increase Decrease Reason For Registration Effective | 25,000 | |||||||||||||||||||||||||||||||
Convertible Debt, Total | $ 4,000,000 | |||||||||||||||||||||||||||||||
Common stock, par value | $ 0.001 | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.60 | |||||||||||||||||||||||||||||||
Debt Instrument, Increase (Decrease), Other, Net | $ 25,000 | |||||||||||||||||||||||||||||||
Debt Issuance Cost | $ 50,000 | |||||||||||||||||||||||||||||||
Warrants Term | 4 years | |||||||||||||||||||||||||||||||
Subsequent Event [Member] | Debenture [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Debt Instrument, Description | payable quarterly in cash (or if certain conditions are met, in stock at the Companys option) on January 1, April 1, July 1 and October 1. The Debenture is convertible at any time, in whole or in part, at the Purchasers option into shares of the Companys common stock, par value $0.001 per share (the Common Stock), at a conversion price equal to $0.042, which is the volume weighted average price of the Companys Common Stock five days prior to the execution of the Debenture (subject to adjustment) (the Conversion Price). At any time after the effective date of the registration statement, the Purchaser has the opportunity to convert up to an aggregate of $2,090,000 of the Debenture, at one or more conversion dates, into shares of Common Stock at a conversion price equal to the VWAP of the Common Stock over the five (5) trading days prior to such Effective Date. The Purchaser option to convert at such a conversion price expires when the Purchaser converts an aggregate of $2,090,000 of the Debenture using such conversion price. If the volume weighted average price of the Company Common Stock on any trading day is less than the Conversion Price, the Purchaser may convert at a price per share equal to a twenty percent (20%) discount to the average of the two lowest closing prices during the five trading days prior to the date of conversion. At no time will the Purchaser be entitled to convert any portion of the Debenture to the extent that after such conversion, the Purchaser (together with its affiliates) would beneficially own more than 4.99% of the outstanding shares of Common Stock as of such date | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.60 | |||||||||||||||||||||||||||||||
Discount On Debt Issued Percentage | 10.00% | |||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 5.00% | |||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Increase (Decrease) | 18.00% | |||||||||||||||||||||||||||||||
Subsequent Event [Member] | Promissory Note [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Proceeds from Notes Payable | 1,150,000 | |||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 1,200,000 | |||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.0346 | |||||||||||||||||||||||||||||||
Debt Instrument, Issuance Date | Sep. 24, 2015 | |||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 1,200,000 | |||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | $ 180,000 | |||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 20.00% | |||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date, Description | The debenture has a maturity date of the earlier of: (i) the date on which the Company closes a subsequent equity offering in an amount greater than the principal amount of the Note; or (ii) June 24, 2016. | |||||||||||||||||||||||||||||||
Promissory Note Payable Issued For Services | 50,000 | |||||||||||||||||||||||||||||||
Notes Payable | $ 1,200,000 | |||||||||||||||||||||||||||||||
Debt Instrument, Description | The Company issued the Promissory Note with a principal amount of $1,200,000 to the Lender. The Promissory Note has a maturity date of the earlier of: (i) the date on which the Company closes a subsequent equity offering in an amount greater than the principal amount of the Promissory Note; or (ii) June 24, 2016. On its face, the Promissory Note does not accrue any interest. In the event that the Lender does not proceed with a subsequent financing, beginning on the 46th day following the Issuance Date, the Note will have a one-time interest adjustment of $180,000 on the outstanding principal of the Promissory Note. Additionally, if the Lender does not wish to proceed with a subsequent financing, the Promissory Note will also be convertible into common stock at the lower of (i) $0.0346; or (ii) a twenty percent (20%) discount to the average of the two lowest closing prices of the common stock in the five trading days prior to the date of conversion. | |||||||||||||||||||||||||||||||
Subsequent Event [Member] | Twentieth Trading [Member] | Debenture [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 125.00% | |||||||||||||||||||||||||||||||
Subsequent Event [Member] | Consultant [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.0415 | $ 0.031 | $ 0.04 | |||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 1,500,000 | 4,000,000 | 8,000,000 | 1,500,000 | 560,000 | |||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 166,000 | $ 46,500 | ||||||||||||||||||||||||||||||
Subsequent Event [Member] | Scientific Advisory Board [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share | $ 0.0369 | |||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 600,000 | |||||||||||||||||||||||||||||||
Subsequent Event [Member] | Consultant One [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 1,100,000 | |||||||||||||||||||||||||||||||
Subsequent Event [Member] | Consultant Two [Member] | ||||||||||||||||||||||||||||||||
Subsequent Event [Line Items] | ||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 400,000 |